151
|
Fang Z, Shi Y, Zhang Y, Zhao Q, Wu J. Reconfigurable Polymer Networks for Digital Light Processing 3D Printing. ACS Appl Mater Interfaces 2021; 13:15584-15590. [PMID: 33755414 DOI: 10.1021/acsami.0c23107] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
To realize a wide range of applications using three-dimensional (3D) printing, it is urgent to develop 3D printing resins with different functions. However, the design freedom of the resin formulation is greatly limited to guarantee fast gelation during 3D printing. Herein, we report a reconfigurable polymer network that is compatible with digital light processing (DLP) 3D printing. The properties of the printed objects can be remanipulated by post-thermal treatment, during which the polymer network undergoes significant changes through the amidation of ester. The Young's modulus could be significantly reduced by 50 times. Specifically, a well-printed rigid part can be completely turned into a low-viscosity liquid. This strategy decouples the printing process and the final material properties, providing an efficient approach to print various functional objects.
Collapse
Affiliation(s)
- Zizheng Fang
- Ningbo Research Institute Zhejiang University, Ningbo 315807, China
- State Key Laboratory of Chemical Engineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China
- ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou 311215, China
| | - Yunpeng Shi
- State Key Laboratory of Chemical Engineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China
| | - Yuhua Zhang
- The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, Zhejiang, China
- Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, Zhejiang, China
| | - Qian Zhao
- Ningbo Research Institute Zhejiang University, Ningbo 315807, China
- State Key Laboratory of Chemical Engineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China
- ZJU-Hangzhou Global Scientific and Technological Innovation Center, Hangzhou 311215, China
| | - Jingjun Wu
- Ningbo Research Institute Zhejiang University, Ningbo 315807, China
- State Key Laboratory of Chemical Engineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310027, China
| |
Collapse
|
152
|
Song R, Shi Y. Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder. Eur Psychiatry 2021. [PMCID: PMC9470394 DOI: 10.1192/j.eurpsy.2021.310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
Introduction Previous study has identified increased antithrombin III (ATIII) in patients with major depressive disorder (MDD), supporting ATIII as a potential biomarker for depression diagnosis. Objectives This study aimed to reveal the alteration of ATIII after occipital repetitive transcranial magnetic stimulation (rTMS), and illuminate its power to evaluate and predict the curative effects in MDD treatment. Methods A total of 90 MDD patients were recruited and further intervened with rTMS in occipital for individualized, standard or sham treatment for five days. Those of 74 patients underwent entire detection, including clinical assessments, blood collection and protein measurement. Results After treatment, decreased ATIII were detected in both the individualized and the standard group (p=0.000 and 0.001, respectively) instead of the sham one. Especially, the reduction in ATIII in the individualized group was associated with improvements in several neuropsychological assessments. Besides, ATIII at baseline in the standard group and after the individualized rTMS showed high performance to evaluate or predict the response to the 5-day treatment (AUC=0.771, 95%CI, 0.571-0.971; AUC=0.875, 95%CI, 0.714-1.000, respectively) and the remission in follow-up (AUC=0.736, 95%CI, 0.529-0.943; AUC=0.828, 95%CI, 0.656-1.000, respectively). Furthermore, both baseline ATIII and change in ATIII involved in the prediction of 24-item Hamilton Depression Rating Scale in the follow-up study with significant predictive values (p=0.0240 and 0.0233, respectively). Conclusions This study detected a reduction in ATIII after occipital rTMS, further revealed the relationships between change in ATIII and therapeutic response, and ultimately provided evidence for the potential of ATIII as a biomarker for the evaluation and prediction of antidepressive effect. Disclosure No significant relationships.
Collapse
|
153
|
Shi Y, Wu L, Yu X, Xing P, Zhou J, Wang A, Shi J, Hu Y, Wang Z, An G, Fang Y, Sun S, Zhou C, Wang C, Ye F, Li X, Wang J, Wang M, Liu Y, Zhao Y. Retraction notice to "30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)": [Annals of Oncology Volume 31, Supplement 7, December 2020, Page S1428]. Ann Oncol 2021; 32:576. [PMID: 33736838 DOI: 10.1016/j.annonc.2021.01.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article was retracted at the request of the authors. The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.
Collapse
Affiliation(s)
- Y Shi
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - L Wu
- Department II of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China
| | - X Yu
- Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China
| | - P Xing
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - J Zhou
- Department of Respiratory Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
| | - A Wang
- The Third Department of Chemotherapy, Weihai Municipal Hospital, Weihai, China
| | - J Shi
- Department of Oncology, Linyi Cancer Hospital, Linyi, China
| | - Y Hu
- Medical Oncology, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Z Wang
- Department I of Thoracic Oncology, Peking University Cancer Hospital & Institute, Beijing, China
| | - G An
- Department of Oncology, Beijing Chao-Yang Hospital, Beijing, China
| | - Y Fang
- Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China
| | - S Sun
- Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou Medical University, Xuzhou, China
| | - C Zhou
- Department of Oncology, Shanghai Pulmonary Hospital, Shanghai, China
| | - C Wang
- Medical Oncology, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin, China
| | - F Ye
- Cancer Hospital, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Teaching Hospital of Fujian Medical University, Department of Medical Oncology, Xiamen, China
| | - X Li
- Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Wang
- Oncology Department, Affiliated Hospital of Jining Medical University, Jining, China
| | - M Wang
- Department of Respiratory Medicine, Peking Union Medical College Hospital, Beijing, China
| | - Y Liu
- Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
| | - Y Zhao
- Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
| |
Collapse
|
154
|
Jin GH, Shi Y, Tian Y, Cao TT, Mao Y, Tang TY. HMGA1 accelerates the malignant progression of gastric cancer through stimulating EMT. Eur Rev Med Pharmacol Sci 2021; 24:3642-3647. [PMID: 32329839 DOI: 10.26355/eurrev_202004_20826] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE To clarify the role of HMGA1 in influencing proliferation and migration abilities, and EMT (epithelial-mesenchymal transition) in gastric cancer (GC) cells. MATERIALS AND METHODS Differential expressions of HMGA1 in GC tissues and normal gastric tissues were analyzed in the GEPIA dataset. Its influence on overall survival of GC patients was evaluated as well. Moreover, HMGA1 levels in GC cells and gastric mucosal cells were detected. Regulatory effects of HMGA1 on the proliferation and migration abilities in SGC7901 and MGC803 cells were assessed through a series of functional experiments. At last, influences of HMGA1 on the expression levels of EMT-related genes, E-cadherin, Snail, and Slug were determined in GC cells. RESULTS Analysis of data in TCGA GEPIA dataset revealed that HMGA1 was upregulated in GC tissues, and GC patients with a high expression level of HMGA1 suffered poorer prognosis. In addition, HMGA1 was identically upregulated in GC cells, and the overexpression of HMGA1 improved the proliferation and migration abilities of SGC7901 and MGC803 cells, downregulated E-cadherin, and upregulated Snail and Slug in GC cells, while silence of HMAG1 yielded the opposite results CONCLUSIONS: HMGA1 is upregulated in GC tissues and predicts poor prognosis, and it aggravates the progression of GC via stimulating EMT.
Collapse
Affiliation(s)
- G-H Jin
- Department of Gastroenterology, The First Hospital of Jilin University, Jilin, China.
| | | | | | | | | | | |
Collapse
|
155
|
Qin WX, Shi Y, Zhu D, Li YP, Chen YH, Cui J, Cui GY, Pan JX, Ren ZY. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p. Eur Rev Med Pharmacol Sci 2021; 24:3204-3214. [PMID: 32271438 DOI: 10.26355/eurrev_202003_20687] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE Glioma is one of the most common and invasive brain tumors worldwide. Long non-coding RNAs (LncRNAs) play an important role in the development of glioma. However, the regulatory mechanism of LncRNAs in glioma has not been fully elucidated. This study aimed to explore the interaction of lncRNA maternally expressed gene 3 (MEG3) and aberrant histone modification in glioma. MATERIALS AND METHODS The expression levels of MEG3 and miR-21-3p in glioma cells were measured by quantitative polymerase chain reaction (qPCR). EZH2 (enhancer of zeste homolog 2) and H3K27me3 expression in glioma cells were detected by Western Blot (WB). The binding site of the promoter of MEG3 by H3K27me3 was confirmed by ChIP-Real-time PCR. The direct target of MEG3 and miR-21-3p in glioma cells was measured by a luciferase reporter assay. Cell proliferation was detected by Cell Counting Kit-8 (CCK8), and cell invasion and migration were measured by Transwell assays. RESULTS EZH2 and miR-21-3p were upregulated and MEG3 was downregulated in glioma cells. Silencing of EZH2 inhibited cell proliferation, migration, and invasion in U87 and U251 cells. Meanwhile, the expression of H3K27me3 could be significantly inhibited by EZH2 interference. H3K27me3 protein can bind to MEG3 promoter directly. EZH2 inhibition and MEG3 down-expression in U87 cells reversed the effects of silencing of EZH2 on glioma cell growth and metastasis. However, EZH2 inhibition and MEG3 overexpression in U251 cells restricted cell proliferation, migration, and invasion. Furthermore, miR-21-3p was verified to interact with MEG3 by direct binding. Inhibition of MEG3 promoted U87 cell growth and metastasis, which was further strengthened following the co-transfection of si-MEG3 and miR-21-3p. Overexpressed MEG3 inhibited U251 cell growth and metastasis and a complete reversal of the results observed in the co-transfection of LV-MEG3 and miR-21-3p. CONCLUSIONS EZH2 was highly expressed in glioma cells and EZH2-mediated H3K27me3 enrichment on the MEG3 promoter regulated the growth and metastasis of glioma cells by targeting miR-21-3p. It potentially provided a new therapeutic marker targeting glioma.
Collapse
Affiliation(s)
- W-X Qin
- Department of Pain Care, Southwest Hospital, Army Medical University, Chongqing, PR China.
| | | | | | | | | | | | | | | | | |
Collapse
|
156
|
Huo YJ, Guo Y, Shi Y, Li L, Wang NL. [Sub-foveal choroidal thickness in both eyes of patients with unilateral primary open-angle glaucoma and related influencing factors]. Zhonghua Yan Ke Za Zhi 2021; 57:194-200. [PMID: 33721958 DOI: 10.3760/cma.j.cn112142-20200412-00262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Objective: To investigate and compare the sub-foveal choroidal thickness (SFCT) in both eyes of patients with unilateral primary open-angle glaucoma (POAG) and healthy controls. Methods: Cross-sectional study. Patients with unilateral POAG and healthy controls were recruited from September 2018 to September 2019 in the Beijing Tongren Hospital. All subjects underwent enhanced depth imaging optical coherence tomography. The SFCT was measured at the fovea, and at 500 μm, 1 000 μm and 2 000 μm nasal and temporal to the fovea. Paired t test was conducted to compare the choroidal thickness between affected POAG eyes and unaffected fellow eyes. Analysis of covariance was conducted to compare the choroidal thicknesses between POAG eyes and controls. Multiple regression analysis determined the association between choroidal thickness and age, gender, spherical equivalent and mean deviation. Results: Seventy-five patients with unilateral POAG (mean age, 46 years; 48 males, 27 females) and 61 healthy controls (mean age, 44 years; 34 males, 27 females) were included in this study. The SFCT of POAG eyes was (244.41±83.18) μm, which was not significantly different from their unaffected fellow eyes [(254.28±88.92) μm, P>0.05] and controls (right eyes) [(272.98±55.87) μm, P>0.05]. Choroidal thickness at 2 000 μm nasal to the fovea was significantly decreased in the glaucomatous eyes compared with the unaffected fellow eyes [(167.84±70.44) vs. (188.84±89.06) μm, t=-3.55; P<0.01]. There were no significant differences among the glaucomatous eyes, unaffected fellow eyes and healthy controls in choroidal thickness at 500 μm and 1 000 μm nasal and temporal to the fovea, as well as at 2 000 μm temporal to the fovea (all P>0.05). The SFCT of POAG eyes was associated with mean deviation (β=14.66, P<0.05) and spherical equivalent (β=14.95, P<0.01) but not with age and gender (both P>0.05). Conclusions: The SFCT of affected eyes in patients with unilateral POAG has no significant difference from unaffected fellow eyes and healthy controls. However, the choroidal thickness at 2 000 μm nasal to the fovea is thinner in the POAG eyes as compared with the fellow eyes. A thinner SFCT is correlated with the loss of visual field and a higher spherical equivalent in myopia. This may suggest a contributing role of the perfusion of the choroid in the pathogenesis of glaucoma. (Chin J Ophthalmol, 2021, 57: 194-200).
Collapse
Affiliation(s)
- Y J Huo
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China
| | - Y Guo
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China
| | - Y Shi
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China
| | - L Li
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China
| | - N L Wang
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China
| |
Collapse
|
157
|
Adam J, Adamczyk L, Adams JR, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Alekseev I, Anderson DM, Aparin A, Aschenauer EC, Ashraf MU, Atetalla FG, Attri A, Averichev GS, Bairathi V, Barish K, Behera A, Bellwied R, Bhasin A, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Brandenburg JD, Brandin AV, Butterworth J, Caines H, Calderón de la Barca Sánchez M, Cebra D, Chakaberia I, Chaloupka P, Chan BK, Chang FH, Chang Z, Chankova-Bunzarova N, Chatterjee A, Chen D, Chen J, Chen JH, Chen X, Chen Z, Cheng J, Cherney M, Chevalier M, Choudhury S, Christie W, Chu X, Crawford HJ, Csanád M, Daugherity M, Dedovich TG, Deppner IM, Derevschikov AA, Didenko L, Dong X, Drachenberg JL, Dunlop JC, Edmonds T, Elsey N, Engelage J, Eppley G, Esumi S, Evdokimov O, Ewigleben A, Eyser O, Fatemi R, Fazio S, Federic P, Fedorisin J, Feng CJ, Feng Y, Filip P, Finch E, Fisyak Y, Francisco A, Fulek L, Gagliardi CA, Galatyuk T, Geurts F, Gibson A, Gopal K, Gou X, Grosnick D, Guryn W, Hamad AI, Hamed A, Harabasz S, Harris JW, He S, He W, He XH, He Y, Heppelmann S, Heppelmann S, Herrmann N, Hoffman E, Holub L, Hong Y, Horvat S, Hu Y, Huang HZ, Huang SL, Huang T, Huang X, Humanic TJ, Huo P, Igo G, Isenhower D, Jacobs WW, Jena C, Jentsch A, Ji Y, Jia J, Jiang K, Jowzaee S, Ju X, Judd EG, Kabana S, Kabir ML, Kagamaster S, Kalinkin D, Kang K, Kapukchyan D, Kauder K, Ke HW, Keane D, Kechechyan A, Kelsey M, Khyzhniak YV, Kikoła DP, Kim C, Kimelman B, Kincses D, Kinghorn TA, Kisel I, Kiselev A, Kocan M, Kochenda L, Kosarzewski LK, Kramarik L, Kravtsov P, Krueger K, Kulathunga Mudiyanselage N, Kumar L, Kumar S, Kunnawalkam Elayavalli R, Kwasizur JH, Lacey R, Lan S, Landgraf JM, Lauret J, Lebedev A, Lednicky R, Lee JH, Leung YH, Li C, Li C, Li W, Li W, Li X, Li Y, Liang Y, Licenik R, Lin T, Lin Y, Lisa MA, Liu F, Liu H, Liu P, Liu P, Liu T, Liu X, Liu Y, Liu Z, Ljubicic T, Llope WJ, Longacre RS, Lukow NS, Luo S, Luo X, Ma GL, Ma L, Ma R, Ma YG, Magdy N, Majka R, Mallick D, Margetis S, Markert C, Matis HS, Mazer JA, Minaev NG, Mioduszewski S, Mohanty B, Mooney I, Moravcova Z, Morozov DA, Nagy M, Nam JD, Nasim M, Nayak K, Neff D, Nelson JM, Nemes DB, Nie M, Nigmatkulov G, Niida T, Nogach LV, Nonaka T, Nunes AS, Odyniec G, Ogawa A, Oh S, Okorokov VA, Page BS, Pak R, Pandav A, Panebratsev Y, Pawlik B, Pawlowska D, Pei H, Perkins C, Pinsky L, Pintér RL, Pluta J, Porter J, Posik M, Pruthi NK, Przybycien M, Putschke J, Qiu H, Quintero A, Radhakrishnan SK, Ramachandran S, Ray RL, Reed R, Ritter HG, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sako H, Salur S, Sandweiss J, Sato S, Schmidke WB, Schmitz N, Schweid BR, Seck F, Seger J, Sergeeva M, Seto R, Seyboth P, Shah N, Shahaliev E, Shanmuganathan PV, Shao M, Sheikh AI, Shen WQ, Shi SS, Shi Y, Shou QY, Sichtermann EP, Sikora R, Simko M, Singh J, Singha S, Smirnov N, Solyst W, Sorensen P, Spinka HM, Srivastava B, Stanislaus TDS, Stefaniak M, Stewart DJ, Strikhanov M, Stringfellow B, Suaide AAP, Sumbera M, Summa B, Sun XM, Sun X, Sun Y, Sun Y, Surrow B, Svirida DN, Szymanski P, Tang AH, Tang Z, Taranenko A, Tarnowsky T, Thomas JH, Timmins AR, Tlusty D, Tokarev M, Tomkiel CA, Trentalange S, Tribble RE, Tribedy P, Tripathy SK, Tsai OD, Tu Z, Ullrich T, Underwood DG, Upsal I, Van Buren G, Vanek J, Vasiliev AN, Vassiliev I, Videbæk F, Vokal S, Voloshin SA, Wang F, Wang G, Wang JS, Wang P, Wang Y, Wang Y, Wang Z, Webb JC, Weidenkaff PC, Wen L, Westfall GD, Wieman H, Wissink SW, Witt R, Wu Y, Xiao ZG, Xie G, Xie W, Xu H, Xu N, Xu QH, Xu YF, Xu Y, Xu Z, Xu Z, Yang C, Yang Q, Yang S, Yang Y, Yang Z, Ye Z, Ye Z, Yi L, Yip K, Yu Y, Zbroszczyk H, Zha W, Zhang C, Zhang D, Zhang S, Zhang S, Zhang XP, Zhang Y, Zhang Y, Zhang ZJ, Zhang Z, Zhang Z, Zhao J, Zhong C, Zhou C, Zhu X, Zhu Z, Zurek M, Zyzak M. Nonmonotonic Energy Dependence of Net-Proton Number Fluctuations. Phys Rev Lett 2021; 126:092301. [PMID: 33750161 DOI: 10.1103/physrevlett.126.092301] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/17/2020] [Revised: 11/19/2020] [Accepted: 01/27/2021] [Indexed: 06/12/2023]
Abstract
Nonmonotonic variation with collision energy (sqrt[s_{NN}]) of the moments of the net-baryon number distribution in heavy-ion collisions, related to the correlation length and the susceptibilities of the system, is suggested as a signature for the quantum chromodynamics critical point. We report the first evidence of a nonmonotonic variation in the kurtosis times variance of the net-proton number (proxy for net-baryon number) distribution as a function of sqrt[s_{NN}] with 3.1 σ significance for head-on (central) gold-on-gold (Au+Au) collisions measured solenoidal tracker at Relativistic Heavy Ion Collider. Data in noncentral Au+Au collisions and models of heavy-ion collisions without a critical point show a monotonic variation as a function of sqrt[s_{NN}].
Collapse
Affiliation(s)
- J Adam
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - L Adamczyk
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J R Adams
- Ohio State University, Columbus, Ohio 43210, USA
| | - J K Adkins
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - G Agakishiev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - Z Ahammed
- Variable Energy Cyclotron Centre, Kolkata 700064, India
| | - I Alekseev
- Alikhanov Institute for Theoretical and Experimental Physics NRC "Kurchatov Institute," Moscow 117218, Russia
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D M Anderson
- Texas A&M University, College Station, Texas 77843, USA
| | - A Aparin
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - E C Aschenauer
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - M U Ashraf
- Central China Normal University, Wuhan, Hubei 430079, China
| | | | - A Attri
- Panjab University, Chandigarh 160014, India
| | - G S Averichev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - V Bairathi
- Instituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile
| | - K Barish
- University of California, Riverside, California 92521, USA
| | - A Behera
- State University of New York, Stony Brook, New York 11794, USA
| | - R Bellwied
- University of Houston, Houston, Texas 77204, USA
| | - A Bhasin
- University of Jammu, Jammu 180001, India
| | - J Bielcik
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - J Bielcikova
- Nuclear Physics Institute of the CAS, Rez 250 68, Czech Republic
| | - L C Bland
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - I G Bordyuzhin
- Alikhanov Institute for Theoretical and Experimental Physics NRC "Kurchatov Institute," Moscow 117218, Russia
| | | | - A V Brandin
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | | | - H Caines
- Yale University, New Haven, Connecticut 06520, USA
| | | | - D Cebra
- University of California, Davis, California 95616, USA
| | - I Chakaberia
- Brookhaven National Laboratory, Upton, New York 11973, USA
- Kent State University, Kent, Ohio 44242, USA
| | - P Chaloupka
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - B K Chan
- University of California, Los Angeles, California 90095, USA
| | - F-H Chang
- National Cheng Kung University, Tainan 70101, Taiwan
| | - Z Chang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | | | - A Chatterjee
- Central China Normal University, Wuhan, Hubei 430079, China
| | - D Chen
- University of California, Riverside, California 92521, USA
| | - J Chen
- Shandong University, Qingdao, Shandong 266237, China
| | - J H Chen
- Fudan University, Shanghai 200433, China
| | - X Chen
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - Z Chen
- Shandong University, Qingdao, Shandong 266237, China
| | - J Cheng
- Tsinghua University, Beijing 100084, China
| | - M Cherney
- Creighton University, Omaha, Nebraska 68178, USA
| | - M Chevalier
- University of California, Riverside, California 92521, USA
| | | | - W Christie
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - X Chu
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - H J Crawford
- University of California, Berkeley, California 94720, USA
| | - M Csanád
- ELTE Eötvös Loránd University, Budapest H-1117, Hungary
| | - M Daugherity
- Abilene Christian University, Abilene, Texas 79699, USA
| | - T G Dedovich
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - I M Deppner
- University of Heidelberg, Heidelberg 69120, Germany
| | - A A Derevschikov
- NRC "Kurchatov Institute", Institute of High Energy Physics, Protvino 142281, Russia
| | - L Didenko
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - X Dong
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - J C Dunlop
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - T Edmonds
- Purdue University, West Lafayette, Indiana 47907, USA
| | - N Elsey
- Wayne State University, Detroit, Michigan 48201, USA
| | - J Engelage
- University of California, Berkeley, California 94720, USA
| | - G Eppley
- Rice University, Houston, Texas 77251, USA
| | - S Esumi
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - O Evdokimov
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - A Ewigleben
- Lehigh University, Bethlehem, Pennsylvania 18015, USA
| | - O Eyser
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Fatemi
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - S Fazio
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - P Federic
- Nuclear Physics Institute of the CAS, Rez 250 68, Czech Republic
| | - J Fedorisin
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - C J Feng
- National Cheng Kung University, Tainan 70101, Taiwan
| | - Y Feng
- Purdue University, West Lafayette, Indiana 47907, USA
| | - P Filip
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - E Finch
- Southern Connecticut State University, New Haven, Connecticut 06515, USA
| | - Y Fisyak
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Francisco
- Yale University, New Haven, Connecticut 06520, USA
| | - L Fulek
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - C A Gagliardi
- Texas A&M University, College Station, Texas 77843, USA
| | - T Galatyuk
- Technische Universität Darmstadt, Darmstadt 64289, Germany
| | - F Geurts
- Rice University, Houston, Texas 77251, USA
| | - A Gibson
- Valparaiso University, Valparaiso, Indiana 46383, USA
| | - K Gopal
- Indian Institute of Science Education and Research (IISER) Tirupati, Tirupati 517507, India
| | - X Gou
- Shandong University, Qingdao, Shandong 266237, China
| | - D Grosnick
- Valparaiso University, Valparaiso, Indiana 46383, USA
| | - W Guryn
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A I Hamad
- Kent State University, Kent, Ohio 44242, USA
| | - A Hamed
- American University of Cairo, New Cairo 11835, New Cairo, Egypt
| | - S Harabasz
- Technische Universität Darmstadt, Darmstadt 64289, Germany
| | - J W Harris
- Yale University, New Haven, Connecticut 06520, USA
| | - S He
- Central China Normal University, Wuhan, Hubei 430079, China
| | - W He
- Fudan University, Shanghai 200433, China
| | - X H He
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, China
| | - Y He
- Shandong University, Qingdao, Shandong 266237, China
| | - S Heppelmann
- University of California, Davis, California 95616, USA
| | - S Heppelmann
- Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - N Herrmann
- University of Heidelberg, Heidelberg 69120, Germany
| | - E Hoffman
- University of Houston, Houston, Texas 77204, USA
| | - L Holub
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - Y Hong
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S Horvat
- Yale University, New Haven, Connecticut 06520, USA
| | - Y Hu
- Fudan University, Shanghai 200433, China
| | - H Z Huang
- University of California, Los Angeles, California 90095, USA
| | - S L Huang
- State University of New York, Stony Brook, New York 11794, USA
| | - T Huang
- National Cheng Kung University, Tainan 70101, Taiwan
| | - X Huang
- Tsinghua University, Beijing 100084, China
| | - T J Humanic
- Ohio State University, Columbus, Ohio 43210, USA
| | - P Huo
- State University of New York, Stony Brook, New York 11794, USA
| | - G Igo
- University of California, Los Angeles, California 90095, USA
| | - D Isenhower
- Abilene Christian University, Abilene, Texas 79699, USA
| | - W W Jacobs
- Indiana University, Bloomington, Indiana 47408, USA
| | - C Jena
- Indian Institute of Science Education and Research (IISER) Tirupati, Tirupati 517507, India
| | - A Jentsch
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y Ji
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - J Jia
- Brookhaven National Laboratory, Upton, New York 11973, USA
- State University of New York, Stony Brook, New York 11794, USA
| | - K Jiang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - S Jowzaee
- Wayne State University, Detroit, Michigan 48201, USA
| | - X Ju
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - E G Judd
- University of California, Berkeley, California 94720, USA
| | - S Kabana
- Instituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile
| | - M L Kabir
- University of California, Riverside, California 92521, USA
| | - S Kagamaster
- Lehigh University, Bethlehem, Pennsylvania 18015, USA
| | - D Kalinkin
- Indiana University, Bloomington, Indiana 47408, USA
| | - K Kang
- Tsinghua University, Beijing 100084, China
| | - D Kapukchyan
- University of California, Riverside, California 92521, USA
| | - K Kauder
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - H W Ke
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D Keane
- Kent State University, Kent, Ohio 44242, USA
| | - A Kechechyan
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - M Kelsey
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Y V Khyzhniak
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - D P Kikoła
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - C Kim
- University of California, Riverside, California 92521, USA
| | - B Kimelman
- University of California, Davis, California 95616, USA
| | - D Kincses
- ELTE Eötvös Loránd University, Budapest H-1117, Hungary
| | - T A Kinghorn
- University of California, Davis, California 95616, USA
| | - I Kisel
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | - A Kiselev
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - M Kocan
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - L Kochenda
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - L K Kosarzewski
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - L Kramarik
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - P Kravtsov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - K Krueger
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | | | - L Kumar
- Panjab University, Chandigarh 160014, India
| | - S Kumar
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, China
| | | | - J H Kwasizur
- Indiana University, Bloomington, Indiana 47408, USA
| | - R Lacey
- State University of New York, Stony Brook, New York 11794, USA
| | - S Lan
- Central China Normal University, Wuhan, Hubei 430079, China
| | - J M Landgraf
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Lauret
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Lebedev
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Lednicky
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - J H Lee
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y H Leung
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - C Li
- Shandong University, Qingdao, Shandong 266237, China
| | - C Li
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - W Li
- Rice University, Houston, Texas 77251, USA
| | - W Li
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - X Li
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - Y Li
- Tsinghua University, Beijing 100084, China
| | - Y Liang
- Kent State University, Kent, Ohio 44242, USA
| | - R Licenik
- Nuclear Physics Institute of the CAS, Rez 250 68, Czech Republic
| | - T Lin
- Texas A&M University, College Station, Texas 77843, USA
| | - Y Lin
- Central China Normal University, Wuhan, Hubei 430079, China
| | - M A Lisa
- Ohio State University, Columbus, Ohio 43210, USA
| | - F Liu
- Central China Normal University, Wuhan, Hubei 430079, China
| | - H Liu
- Indiana University, Bloomington, Indiana 47408, USA
| | - P Liu
- State University of New York, Stony Brook, New York 11794, USA
| | - P Liu
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - T Liu
- Yale University, New Haven, Connecticut 06520, USA
| | - X Liu
- Ohio State University, Columbus, Ohio 43210, USA
| | - Y Liu
- Texas A&M University, College Station, Texas 77843, USA
| | - Z Liu
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - T Ljubicic
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - W J Llope
- Wayne State University, Detroit, Michigan 48201, USA
| | - R S Longacre
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N S Lukow
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - S Luo
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - X Luo
- Central China Normal University, Wuhan, Hubei 430079, China
| | - G L Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - L Ma
- Fudan University, Shanghai 200433, China
| | - R Ma
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y G Ma
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - N Magdy
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - R Majka
- Yale University, New Haven, Connecticut 06520, USA
| | - D Mallick
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - S Margetis
- Kent State University, Kent, Ohio 44242, USA
| | - C Markert
- University of Texas, Austin, Texas 78712, USA
| | - H S Matis
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - J A Mazer
- Rutgers University, Piscataway, New Jersey 08854, USA
| | - N G Minaev
- NRC "Kurchatov Institute", Institute of High Energy Physics, Protvino 142281, Russia
| | | | - B Mohanty
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - I Mooney
- Wayne State University, Detroit, Michigan 48201, USA
| | - Z Moravcova
- Czech Technical University in Prague, FNSPE, Prague 115 19, Czech Republic
| | - D A Morozov
- NRC "Kurchatov Institute", Institute of High Energy Physics, Protvino 142281, Russia
| | - M Nagy
- ELTE Eötvös Loránd University, Budapest H-1117, Hungary
| | - J D Nam
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - Md Nasim
- Indian Institute of Science Education and Research (IISER), Berhampur 760010, India
| | - K Nayak
- Central China Normal University, Wuhan, Hubei 430079, China
| | - D Neff
- University of California, Los Angeles, California 90095, USA
| | - J M Nelson
- University of California, Berkeley, California 94720, USA
| | - D B Nemes
- Yale University, New Haven, Connecticut 06520, USA
| | - M Nie
- Shandong University, Qingdao, Shandong 266237, China
| | - G Nigmatkulov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Niida
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - L V Nogach
- NRC "Kurchatov Institute", Institute of High Energy Physics, Protvino 142281, Russia
| | - T Nonaka
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - A S Nunes
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - G Odyniec
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A Ogawa
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S Oh
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - V A Okorokov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - B S Page
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - R Pak
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Pandav
- National Institute of Science Education and Research, HBNI, Jatni 752050, India
| | - Y Panebratsev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - B Pawlik
- Institute of Nuclear Physics PAN, Cracow 31-342, Poland
| | - D Pawlowska
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - H Pei
- Central China Normal University, Wuhan, Hubei 430079, China
| | - C Perkins
- University of California, Berkeley, California 94720, USA
| | - L Pinsky
- University of Houston, Houston, Texas 77204, USA
| | - R L Pintér
- ELTE Eötvös Loránd University, Budapest H-1117, Hungary
| | - J Pluta
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - J Porter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - N K Pruthi
- Panjab University, Chandigarh 160014, India
| | - M Przybycien
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - J Putschke
- Wayne State University, Detroit, Michigan 48201, USA
| | - H Qiu
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, China
| | - A Quintero
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | | | - S Ramachandran
- University of Kentucky, Lexington, Kentucky 40506-0055, USA
| | - R L Ray
- University of Texas, Austin, Texas 78712, USA
| | - R Reed
- Lehigh University, Bethlehem, Pennsylvania 18015, USA
| | - H G Ritter
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | | | - J L Romero
- University of California, Davis, California 95616, USA
| | - L Ruan
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Rusnak
- Nuclear Physics Institute of the CAS, Rez 250 68, Czech Republic
| | - N R Sahoo
- Shandong University, Qingdao, Shandong 266237, China
| | - H Sako
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - S Salur
- Rutgers University, Piscataway, New Jersey 08854, USA
| | - J Sandweiss
- Yale University, New Haven, Connecticut 06520, USA
| | - S Sato
- University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - W B Schmidke
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N Schmitz
- Max-Planck-Institut für Physik, Munich 80805, Germany
| | - B R Schweid
- State University of New York, Stony Brook, New York 11794, USA
| | - F Seck
- Technische Universität Darmstadt, Darmstadt 64289, Germany
| | - J Seger
- Creighton University, Omaha, Nebraska 68178, USA
| | - M Sergeeva
- University of California, Los Angeles, California 90095, USA
| | - R Seto
- University of California, Riverside, California 92521, USA
| | - P Seyboth
- Max-Planck-Institut für Physik, Munich 80805, Germany
| | - N Shah
- Indian Institute of Technology, Patna, Bihar 801106, India
| | - E Shahaliev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | | | - M Shao
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - A I Sheikh
- Kent State University, Kent, Ohio 44242, USA
| | - W Q Shen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - S S Shi
- Central China Normal University, Wuhan, Hubei 430079, China
| | - Y Shi
- Shandong University, Qingdao, Shandong 266237, China
| | - Q Y Shou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - E P Sichtermann
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - R Sikora
- AGH University of Science and Technology, FPACS, Cracow 30-059, Poland
| | - M Simko
- Nuclear Physics Institute of the CAS, Rez 250 68, Czech Republic
| | - J Singh
- Panjab University, Chandigarh 160014, India
| | - S Singha
- Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 730000, China
| | - N Smirnov
- Yale University, New Haven, Connecticut 06520, USA
| | - W Solyst
- Indiana University, Bloomington, Indiana 47408, USA
| | - P Sorensen
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - H M Spinka
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - B Srivastava
- Purdue University, West Lafayette, Indiana 47907, USA
| | | | - M Stefaniak
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - D J Stewart
- Yale University, New Haven, Connecticut 06520, USA
| | - M Strikhanov
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | | | - A A P Suaide
- Universidade de São Paulo, São Paulo 05314-970, Brazil
| | - M Sumbera
- Nuclear Physics Institute of the CAS, Rez 250 68, Czech Republic
| | - B Summa
- Pennsylvania State University, University Park, Pennsylvania 16802, USA
| | - X M Sun
- Central China Normal University, Wuhan, Hubei 430079, China
| | - X Sun
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - Y Sun
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - Y Sun
- Huzhou University, Huzhou, Zhejiang 313000, China
| | - B Surrow
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - D N Svirida
- Alikhanov Institute for Theoretical and Experimental Physics NRC "Kurchatov Institute," Moscow 117218, Russia
| | - P Szymanski
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - A H Tang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Z Tang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - A Taranenko
- National Research Nuclear University MEPhI, Moscow 115409, Russia
| | - T Tarnowsky
- Michigan State University, East Lansing, Michigan 48824, USA
| | - J H Thomas
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - A R Timmins
- University of Houston, Houston, Texas 77204, USA
| | - D Tlusty
- Creighton University, Omaha, Nebraska 68178, USA
| | - M Tokarev
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - C A Tomkiel
- Lehigh University, Bethlehem, Pennsylvania 18015, USA
| | - S Trentalange
- University of California, Los Angeles, California 90095, USA
| | - R E Tribble
- Texas A&M University, College Station, Texas 77843, USA
| | - P Tribedy
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S K Tripathy
- ELTE Eötvös Loránd University, Budapest H-1117, Hungary
| | - O D Tsai
- University of California, Los Angeles, California 90095, USA
| | - Z Tu
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - T Ullrich
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D G Underwood
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - I Upsal
- Brookhaven National Laboratory, Upton, New York 11973, USA
- Shandong University, Qingdao, Shandong 266237, China
| | - G Van Buren
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J Vanek
- Nuclear Physics Institute of the CAS, Rez 250 68, Czech Republic
| | - A N Vasiliev
- NRC "Kurchatov Institute", Institute of High Energy Physics, Protvino 142281, Russia
| | - I Vassiliev
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| | - F Videbæk
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S Vokal
- Joint Institute for Nuclear Research, Dubna 141 980, Russia
| | - S A Voloshin
- Wayne State University, Detroit, Michigan 48201, USA
| | - F Wang
- Purdue University, West Lafayette, Indiana 47907, USA
| | - G Wang
- University of California, Los Angeles, California 90095, USA
| | - J S Wang
- Huzhou University, Huzhou, Zhejiang 313000, China
| | - P Wang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - Y Wang
- Central China Normal University, Wuhan, Hubei 430079, China
| | - Y Wang
- Tsinghua University, Beijing 100084, China
| | - Z Wang
- Shandong University, Qingdao, Shandong 266237, China
| | - J C Webb
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | | | - L Wen
- University of California, Los Angeles, California 90095, USA
| | - G D Westfall
- Michigan State University, East Lansing, Michigan 48824, USA
| | - H Wieman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - S W Wissink
- Indiana University, Bloomington, Indiana 47408, USA
| | - R Witt
- United States Naval Academy, Annapolis, Maryland 21402, USA
| | - Y Wu
- University of California, Riverside, California 92521, USA
| | - Z G Xiao
- Tsinghua University, Beijing 100084, China
| | - G Xie
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - W Xie
- Purdue University, West Lafayette, Indiana 47907, USA
| | - H Xu
- Huzhou University, Huzhou, Zhejiang 313000, China
| | - N Xu
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Q H Xu
- Shandong University, Qingdao, Shandong 266237, China
| | - Y F Xu
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - Y Xu
- Shandong University, Qingdao, Shandong 266237, China
| | - Z Xu
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Z Xu
- University of California, Los Angeles, California 90095, USA
| | - C Yang
- Shandong University, Qingdao, Shandong 266237, China
| | - Q Yang
- Shandong University, Qingdao, Shandong 266237, China
| | - S Yang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y Yang
- National Cheng Kung University, Tainan 70101, Taiwan
| | - Z Yang
- Central China Normal University, Wuhan, Hubei 430079, China
| | - Z Ye
- Rice University, Houston, Texas 77251, USA
| | - Z Ye
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - L Yi
- Shandong University, Qingdao, Shandong 266237, China
| | - K Yip
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y Yu
- Shandong University, Qingdao, Shandong 266237, China
| | - H Zbroszczyk
- Warsaw University of Technology, Warsaw 00-661, Poland
| | - W Zha
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - C Zhang
- State University of New York, Stony Brook, New York 11794, USA
| | - D Zhang
- Central China Normal University, Wuhan, Hubei 430079, China
| | - S Zhang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - S Zhang
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - X P Zhang
- Tsinghua University, Beijing 100084, China
| | - Y Zhang
- University of Science and Technology of China, Hefei, Anhui 230026, China
| | - Y Zhang
- Central China Normal University, Wuhan, Hubei 430079, China
| | - Z J Zhang
- National Cheng Kung University, Tainan 70101, Taiwan
| | - Z Zhang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Z Zhang
- University of Illinois at Chicago, Chicago, Illinois 60607, USA
| | - J Zhao
- Purdue University, West Lafayette, Indiana 47907, USA
| | - C Zhong
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - C Zhou
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
| | - X Zhu
- Tsinghua University, Beijing 100084, China
| | - Z Zhu
- Shandong University, Qingdao, Shandong 266237, China
| | - M Zurek
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Zyzak
- Frankfurt Institute for Advanced Studies FIAS, Frankfurt 60438, Germany
| |
Collapse
|
158
|
Zheng L, Liu S, Lv X, Shi Y. Use of facial vein graft with vascularized composite auricular helical rim flap for alar rim defects. Int J Oral Maxillofac Surg 2021; 50:1435-1439. [PMID: 33678491 DOI: 10.1016/j.ijom.2021.02.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2020] [Revised: 01/04/2021] [Accepted: 02/12/2021] [Indexed: 11/30/2022]
Abstract
Nasal alar defects lead to facial disfigurement, and nasal ala reconstruction is an important treatment option. The vascularized composite auricular flap based on the superficial temporal artery is an ideal option for a full-thickness nasal alar defect. However, the pedicle length and the discrepancy in artery diameter between the recipient vessel and flap pedicle continue to be major problems for free auricular composite tissue transfer. Considering that the angular artery is occasionally absent and the course of the infraorbital segment of the facial vein is constant, there are often no suitable vessels around the recipient site for anastomoses to the short pedicle of the flap. In the absence of a suitable recipient artery, an infraorbital segment of the facial vein measuring 2.5cm in length was taken as a graft for the anastomosis of the superficial temporal artery and superior labial artery. End-to-end anastomosis was performed easily. The flap was inset to reconstruct the contralateral ala. The facial vein graft for anastomosis of the superficial temporal artery and branch of the facial artery is a reliable and easy method to resolve the problem of a short pedicle and large artery discrepancy for nasal ala reconstruction with a vascularized composite helical rim flap.
Collapse
Affiliation(s)
- L Zheng
- Department of Oral and Maxillofacial Surgery, Peking University School of Stomatology, Beijing, PR China.
| | - S Liu
- Department of Oral and Maxillofacial Surgery, Peking University School of Stomatology, Beijing, PR China
| | - X Lv
- Department of Oral and Maxillofacial Surgery, Peking University School of Stomatology, Beijing, PR China
| | - Y Shi
- Department of Oral and Maxillofacial Surgery, Peking University School of Stomatology, Beijing, PR China
| |
Collapse
|
159
|
Tang W, Huang X, Liu Y, Lv Q, Li T, Song Y, Zhang X, Chen X, Shi Y. A novel homozygous mutation (p.N958K) of SLC12A3 in Gitelman syndrome is associated with endoplasmic reticulum stress. J Endocrinol Invest 2021; 44:471-480. [PMID: 32642858 DOI: 10.1007/s40618-020-01329-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/25/2020] [Accepted: 06/05/2020] [Indexed: 12/21/2022]
Abstract
PURPOSE Gitelman syndrome (GS) is an autosomal recessive renal tubular disease that arises as a consequence of mutations in the SLC12A3 gene, which codes for an Na-Cl cotransporter (NCC) in distal renal tubules. This study was designed to explore the mutations associated with GS in an effort to more fully understand the molecular mechanisms governing GS. METHODS We analyzed SLC12A3 mutations in a pedigree including a 42-year-old male with GS as well as four related family members over three generations using Sanger and next generation sequencing approaches. We additionally explored the functional ramifications of identified mutations using both Xenopus oocytes and the HEK293T cell line. RESULTS We found that the subject with GS exhibited characteristic symptoms including sporadic thirst, fatigue, excess urination, and substantial hypokalemia and hypocalciuria, although magnesium levels were normal. Other analyzed subjects in this pedigree had normal laboratory findings and did not exhibit clear signs of GS. Sequencing analyses revealed that the GS subject exhibited a homozygous missense mutation (c.2874C > G, p.N958K) in exon 24 of SLC12A3. Both parents of this GS subject, as well as his older brother and daughter all exhibited heterozygous mutations at this same site. Functional analyses in Xenopus oocytes indicated that this mutated SLC12A3 gene encodes a protein which fails to mediate normal sodium transport, and when this mutant gene was expressed in HEK293T cells, we observed significant increases in endoplasmic reticulum (ER)-stress pathway activation. CONCLUSION The p.N958K mutation in exon 24 of SLC12A3 can trigger GS at least in part via enhancing ER stress responses.
Collapse
Affiliation(s)
- W Tang
- Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
| | - X Huang
- Department of Ophthalmology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
| | - Y Liu
- Department of Gastroenterology, The Third People's Hospital of Honghe Prefecture, Gejiu, 661000, Yunnan, China
| | - Q Lv
- Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
| | - T Li
- Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
| | - Y Song
- Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
| | - X Zhang
- Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China
| | - X Chen
- Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China.
| | - Y Shi
- Department of Endocrinology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, China.
| |
Collapse
|
160
|
Shao Z, Wang B, Shi Y, Xie C, Huang C, Chen B, Zhang H, Zeng G, Liang H, Wu Y, Zhou Y, Tian N, Wu A, Gao W, Wang X, Zhang X. Senolytic agent Quercetin ameliorates intervertebral disc degeneration via the Nrf2/NF-κB axis. Osteoarthritis Cartilage 2021; 29:413-422. [PMID: 33242601 DOI: 10.1016/j.joca.2020.11.006] [Citation(s) in RCA: 85] [Impact Index Per Article: 28.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Revised: 10/24/2020] [Accepted: 11/15/2020] [Indexed: 02/02/2023]
Abstract
OBJECTIVE Intervertebral disc degeneration (IDD) represents major cause of low back pain. Quercetin (QUE) is one of the approved senolytic agents. In this study, we evaluated the protective effects of QUE on IDD development and its underlying mechanism. METHODS Effects of senolytic agent QUE on the viability of nucleus pulposus cells (NPCs) were measured by CCK-8 assays and EdU staining. The senescence associated secreted phenotype (SASP) factors expressions were measured by qPCR, western blot, and ELISA; and NF-κB pathway was detected by immunofluorescence and western blot. Molecular docking was applied to predict the interacting protein of QUE; while Nrf2 was knocked down by siRNAs to confirm its role in QUE regulated senescence phenotype. X-ray, MRI, Hematoxylin-Eosin and Safranin O-Fast green staining were performed to evaluate the therapeutic effects of QUE on IDD in the puncture-induced rat model. RESULTS In in vitro experiments, QUE inhibited SASP factors expression and senescence phenotype in IL-1β-treated NPCs. Mechanistically, QUE suppressed IL-1β induced activation of the NF-κB pathway cascades; it was also demonstrated in molecular docking and knock down studies that QUE might bind to Keap1-Nrf2 complex to suppress NF-κB pathway. In vivo, QUE ameliorated the IDD process in the puncture-induced rat model. CONCLUSIONS Together the present work suggests that QUE inhibits SASP factors expression and senescence phenotype in NPCs and ameliorates the progression of IDD via the Nrf2/NF-κB axis, which supports senolytic agent QUE as a potential therapeutic agent for the treatment of IDD.
Collapse
Affiliation(s)
- Z Shao
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - B Wang
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - Y Shi
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - C Xie
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - C Huang
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - B Chen
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - H Zhang
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - G Zeng
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - H Liang
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - Y Wu
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - Y Zhou
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - N Tian
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - A Wu
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - W Gao
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China
| | - X Wang
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
| | - X Zhang
- Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, Zhejiang Province, China; The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Chinese Orthopaedic Regenerative Medicine Society, Hangzhou, Zhejiang Province, China.
| |
Collapse
|
161
|
Feng Y, Zhu H, Hu X, Liu Y, Xing P, Wang H, Ji X, Dai Z, Shi Y. P76.50 Analysis of Efficacy and Safety of First Generation EGFR-TKI plus Apatinib in Treating Advanced NSCLC after EGFR-TKI Treatment Failure. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
162
|
Hu X, Yuan M, Feng Y, Zhang T, Zhang L, Dong G, Zhu H, Liu Y, Xing P, Wang H, Li B, Shi Y, Chen R, Xia X. P47.08 Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Clinical Benefit of Immunotherapy in Small-Cell Lung Cancer. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
163
|
Shi Y, Hu X, Liao W, Zhang S, Wang Z, Yang N, Wu L, Zhou J, Ying K, Ma Z, Feng J, Liu L, Qin S, Fang J, Zhang X, Jiang Y, Ge N. P76.65 CNS Efficacy of AST2818 in Patients with T790M-Positive Advanced NSCLC: Data from a Phase I-II Dose-Expansion Study. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
164
|
Zhao F, Zheng L, Shan F, Dai Y, Shen J, Yang S, Shi Y, Xue K, Zhang Z. Evaluation of pulmonary ventilation in COVID-19 patients using oxygen-enhanced three-dimensional ultrashort echo time MRI: a preliminary study. Clin Radiol 2021; 76:391.e33-391.e41. [PMID: 33712292 PMCID: PMC7906509 DOI: 10.1016/j.crad.2021.02.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2020] [Accepted: 02/17/2021] [Indexed: 01/15/2023]
Abstract
AIM To evaluate the lung function of coronavirus disease 2019 (COVID-19) patients using oxygen-enhanced (OE) ultrashort echo time (UTE) MRI. MATERIALS AND METHODS Forty-nine patients with COVID-19 were included in the study. The OE-MRI was based on a respiratory-gated three-dimensional (3D) radial UTE sequence. For each patient, the percent signal enhancement (PSE) map was calculated using the expression PSE = (S100% – S21%)/S21%, where S21% and S100% are signals acquired during room air and 100% oxygen inhalation, respectively. Agreement of lesion detectability between UTE-MRI and computed tomography (CT) was performed using the kappa test. The Mann–Whitney U-test was used to evaluate the difference in the mean PSE between mild-type COVID-19 and common-type COVID-19. Spearman's test was used to assess the relationship between lesion mean PSE and lesion size. Furthermore, the Mann–Whitney U-test was used to evaluate the difference in region of interest (ROI) mean PSE between normal pulmonary parenchyma and lesions. The Kruskal–Wallis test was applied to test the difference in the mean PSE between different lesion types. RESULTS CT and UTE-MRI reached good agreement in lesion detectability. Ventilation measures in mild-type patients (5.3 ± 5.5%) were significantly different from those in common-type patients (3 ± 3.9%). Besides, there was no significant correlation between lesion mean PSE and lesion size. The mean PSE of COVID-19 lesions (3.2 ± 4.9%) was significantly lower than that of the pulmonary parenchyma (5.4 ± 3.9%). No significant difference was found among different lesion types. CONCLUSION OE-UTE-MRI could serve as a promising method for the assessment of lung function or treatment management of COVID-19 patients.
Collapse
Affiliation(s)
- F Zhao
- Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China; Department of Radiology, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - L Zheng
- MR Collaboration, Central Research Institute, United Imaging Healthcare, Shanghai 201800, China
| | - F Shan
- Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
| | - Y Dai
- MR Collaboration, Central Research Institute, United Imaging Healthcare, Shanghai 201800, China
| | - J Shen
- Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
| | - S Yang
- Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
| | - Y Shi
- Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
| | - K Xue
- MR Collaboration, Central Research Institute, United Imaging Healthcare, Shanghai 201800, China
| | - Z Zhang
- Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China; Department of the Principal's Office, Fudan University, Shanghai 200433, China.
| |
Collapse
|
165
|
Shen SJ, Xu YL, Zhou YD, Ren GS, Jiang J, Jiang HC, Zhang J, Li B, Jin F, Li YP, Xie FM, Shi Y, Wang ZD, Sun M, Yuan SH, Yu JJ, Chen Y, Sun Q. [A comparative study of breast cancer mass screening and opportunistic screening in Chinese women]. Zhonghua Wai Ke Za Zhi 2021; 59:109-115. [PMID: 33378802 DOI: 10.3760/cma.j.cn112139-20201015-00753] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To compare the population characteristics, the positive rate of screening, the detection rate of breast cancer, early diagnosis rate and the cost between the mass screening group and opportunistic screening group of breast cancer. Methods: This study is a prospective multicenter cohort study conducted from January 1, 2014 to December 31, 2016. The participants were enrolled for mass screening or opportunistic screening of breast cancer. After completing the questionnaire, all the participants received breast physical examination and breast ultrasound examination every year for 3 rounds by year. The participants' characteristics and screening results of the two groups were compared by χ2 test, Fisher exact test or Wilcoxon rank-sum test. Results: A total of 20 080 subjects were enrolled. In the mass screening group, 9 434 (100%), 8 111 (85.98%) and 3 940 (41.76%) cases completed the 3 rounds of screening, and 10 646 (100%), 6 209 (58.32%) and 2 988 (28.07%) cases in the opportunistic screening group, respectively. In the opportunistic screening group, the proportions of less than 3 months lactation (1 275/9 796 vs. 1 061/8 860, χ²=4.597, P=0.032), non-fertility (850/10 646 vs. 574/9 434, χ²=27.400, P<0.01), abortion history (6 384/10 646 vs. 5 062/9 434, χ²=81.232, P<0.01), postmenopausal (2 776/10 646 vs. 2 217/9 434, χ²=17.757, P<0.01), long-term oral contraceptives(>6 months) (171/10 646 vs. 77/9 434, χ²=25.593, P<0.01) and family history of breast cancer in first-degree relatives (464/10 646 vs. 236/9 434, χ²=51.257, P<0.01) were significantly higher than those in mass screening group. The positive rate of screening (514/10 646 vs. 128/9 434, χ²=194.736, P<0.01), the detection rate of breast cancer (158/10 646 vs. 13/9 434, χ²=107.374, P<0.01), and positive rate of biopsy (158/452 vs. 13/87, χ²=13.491, P<0.01) in the opportunistic screening group were significantly higher than those of the mass screening group. The early diagnosis rate of the mass screening group was significantly higher than the opportunistic screening group (10/12 vs. 66/141, χ²=5.902, P=0.015). The average cost for detecting each breast cancer case of the mass screening group was 215 038 CNY, which was 13.6 times of the opportunistic screening group (15 799 CNY/case). In the opportunistic screening group, the positive rate of biopsy in primary hospitals was significantly lower than that in large-volume hospitals (79/267 vs. 79/185, χ²=8.267, P=0.004), but there was no significant difference in the mass screening group (6/37 vs. 7/50, χ²=0.082, P=0.774). Conclusions: Breast cancer screening can improve early detection rate. Compared with the mass screening mode, the opportunistic screening mode has the advantages of higher proportion of high-risk factors, higher positive rate of screening, higher detection rate of breast cancer, higher positive rate of biopsy, and lower cost of screening. However, the early diagnosis rate of breast cancer of opportunistic screening is lower than that of mass screening. The positive rate of opportunistic screening in primary hospitals is lower than that of large-volume hospitals. The two screening modes have their own advantages and should be chosen according to local conditions of different regions in China.
Collapse
Affiliation(s)
- S J Shen
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Y L Xu
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - Y D Zhou
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - G S Ren
- Department of Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
| | - J Jiang
- Department of Breast Surgery, the Southwest Hospital of Army Medical University, Chongqing 400038, China
| | - H C Jiang
- Department of Breast Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - J Zhang
- Department of Breast Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - B Li
- Department of Breast Surgery, Beijing Hospital, Beijing 100005, China
| | - F Jin
- Department of Breast Surgery, the First Affiliated Hospital of China Medical University, Shenyang 110001, China
| | - Y P Li
- Department of General Surgery, Chifeng Baoshan Hospital, Chifeng 024076, Inner Mongolia Autonomous Region, China
| | - F M Xie
- Department of General Surgery, the First People's Hospital of Hani-Yi Autonomous Prefecture of Honghe, Mengzi 661100, Yunnan Province, China
| | - Y Shi
- Department of Breast, Shanxi Institute of Traditional Chinese Medicine, Taiyuan 030012, China
| | - Z D Wang
- Department of General Surgery, Ordos Central Hospital, Ordos 017299, Inner Mongolia Autonomous Region, China
| | - M Sun
- Department of Breast Surgery, Qingdao Municipal Hospital, Qingdao 266011, China
| | - S H Yuan
- Department of Breast Surgery, Hospital of Xinjiang Production and Construction Corps, Urumqi 830002, China
| | - J J Yu
- Department of Breast Surgery, Xingtai Third Hospital, Xingtai 054000, Hebei Province, China
| | - Y Chen
- Hubei Yingshan Maternal and Child Health Care Hospital, Huanggang 438700, Hubei Province, China
| | - Q Sun
- Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| |
Collapse
|
166
|
Shi Y, Li K, Xu K, Liu QH. MiR-155-5p accelerates cerebral ischemia-reperfusion injury via targeting DUSP14 by regulating NF-κB and MAPKs signaling pathways. Eur Rev Med Pharmacol Sci 2021; 24:1408-1419. [PMID: 32096190 DOI: 10.26355/eurrev_202002_20198] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE This study aimed to explore the role of miR-155-5p in middle cerebral artery occlusion/reperfusion (MCAO/R) model in rats and oxygen-glucose deprivation/reoxygenation (OGD/R)-induced SH-SY5Y cells. In addition, this study also aimed to explore the underlying mechanisms to expect that miR-155-5p may be investigated as a new and effective diagnostic and therapeutic target for ischemic stroke. MATERIALS AND METHODS The in vivo MCAO/R rat model and in vitro OGD/R cell model were established. The miR-155-5p mRNA expression was detected by quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). Dual specificity ATPase (DUSP) 14 was predicted to be a potential target of miR-155-5p by TargetScan. The targeting relationship was confirmed by Luciferase assay. The cell viability was determined using the Cell Counting Kit-8 (CCK-8). The expression level of inflammatory cytokines, including tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) levels were detected by Enzyme-Linked Immunosorbent Assay (ELISA). Western blot was used to detect the protein expression of DUSP14, the apoptotic protein Cleaved cysteine-aspartic acid protease (caspase)-3, and Cleaved PARP, as well as nuclear factor kappa B (NF-κB) and MAPKs signaling pathways related proteins. RESULTS MiR-155-5p was upregulated in both MCAO/R rats and OGD/R-induced SH-SY5Y cells. MiR-155-5p knockdown inhibited OGD/R-induced cell injury and inflammation, as well as MCAO/R-induced brain injury. MiR-155-5p regulated the NF-κB and MAPKs signaling pathways by targeting DUSP14. DUSP14 knockdown partially reversed the protective effect of miR-155-5p knockdown on OGD/R-induced SH-SY5Y cell injury and inflammation. CONCLUSIONS MiR-155-5p accelerates cerebral I/R injury via targeting DUSP14 by regulating NF-κB and MAPKs signaling pathways. Inhibition of miR-155-5p significantly reduces apoptosis and brain injury. These results indicated that miR-155-5p plays a key role in cerebral I/R injury and has the potential to be explored as a new target for ischemic stroke.
Collapse
Affiliation(s)
- Y Shi
- Department of Neurology, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, China.
| | | | | | | |
Collapse
|
167
|
Concepcion FA, Khan MN, Ju Wang JD, Wei AD, Ojemann JG, Ko AL, Shi Y, Eng JK, Ramirez JM, Poolos NP. HCN Channel Phosphorylation Sites Mapped by Mass Spectrometry in Human Epilepsy Patients and in an Animal Model of Temporal Lobe Epilepsy. Neuroscience 2021; 460:13-30. [PMID: 33571596 DOI: 10.1016/j.neuroscience.2021.01.038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Revised: 01/07/2021] [Accepted: 01/26/2021] [Indexed: 10/22/2022]
Abstract
Because hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels modulate the excitability of cortical and hippocampal principal neurons, these channels play a key role in the hyperexcitability that occurs during the development of epilepsy after a brain insult, or epileptogenesis. In epileptic rats generated by pilocarpine-induced status epilepticus, HCN channel activity is downregulated by two main mechanisms: a hyperpolarizing shift in gating and a decrease in amplitude of the current mediated by HCN channels, Ih. Because these mechanisms are modulated by various phosphorylation signaling pathways, we hypothesized that phosphorylation changes occur at individual HCN channel amino acid residues (phosphosites) during epileptogenesis. We collected CA1 hippocampal tissue from male Sprague Dawley rats made epileptic by pilocarpine-induced status epilepticus, and age-matched naïve controls. We also included resected human brain tissue containing epileptogenic zones (EZs) where seizures arise for comparison to our chronically epileptic rats. After enrichment for HCN1 and HCN2 isoforms by immunoprecipitation and trypsin in-gel digestion, the samples were analyzed by mass spectrometry. We identified numerous phosphosites from HCN1 and HCN2 channels, representing a novel survey of phosphorylation sites within HCN channels. We found high levels of HCN channel phosphosite homology between humans and rats. We also identified a novel HCN1 channel phosphosite S791, which underwent significantly increased phosphorylation during the chronic epilepsy stage. Heterologous expression of a phosphomimetic mutant, S791D, replicated a hyperpolarizing shift in Ih gating seen in neurons from chronically epileptic rats. These results show that HCN1 channel phosphorylation is altered in epilepsy and may be of pathogenic importance.
Collapse
Affiliation(s)
- F A Concepcion
- Department of Neurology and Regional Epilepsy Center, University of Washington, Seattle, WA, United States
| | - M N Khan
- Department of Neurology and Regional Epilepsy Center, University of Washington, Seattle, WA, United States
| | - J-D Ju Wang
- Seattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA, United States
| | - A D Wei
- Seattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA, United States
| | - J G Ojemann
- Seattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA, United States; Department of Neurological Surgery, University of Washington, Seattle, WA, United States
| | - A L Ko
- Department of Neurological Surgery, University of Washington, Seattle, WA, United States
| | - Y Shi
- Department of Electrical and Computer Engineering, University of Washington, Seattle, WA, United States
| | - J K Eng
- Proteomics Resource, University of Washington, Seattle, WA, United States
| | - J-M Ramirez
- Seattle Children's Research Institute, Center for Integrative Brain Research, Seattle, WA, United States; Department of Neurological Surgery, University of Washington, Seattle, WA, United States
| | - N P Poolos
- Department of Neurology and Regional Epilepsy Center, University of Washington, Seattle, WA, United States.
| |
Collapse
|
168
|
An R, Shi Y, Shen J, Bullard T, Liu G, Yang Q, Chen N, Cao L. Effect of front-of-package nutrition labeling on food purchases: a systematic review. Public Health 2021; 191:59-67. [PMID: 33517247 DOI: 10.1016/j.puhe.2020.06.035] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2020] [Revised: 06/15/2020] [Accepted: 06/16/2020] [Indexed: 10/22/2022]
Abstract
OBJECTIVES This study systematically reviewed evidence from interventions on the effect of front-of-package (FOP) nutrition labeling on food purchases. STUDY DESIGN The study design used in this study is a systematic review. METHODS Keyword search was performed in PubMed, Web of Science, Scopus, and Cochrane Library. RESULTS Fifteen studies (10 randomized controlled trials, four pre-post studies, and one case-control study) met the eligibility criteria and were included in the review. Five studies were conducted in a controlled setting through the establishment of an online virtual supermarket or physical laboratory food store solely for the intervention. In contrast, the remaining ten studies were conducted in a naturalistic setting where people commonly purchase foods (e.g., supermarket, grocery store, school/hospital cafeteria, or vending machine). FOP labels assessed included traffic lights, health star rating, daily intake guides, health warnings, and high sugar symbol labels. Compared with the control, FOP labels were effective for helping participants make healthier food purchase decisions in five of the 12 studies that assessed traffic lights labels, in one of the two studies that assessed health warning labels, and in one study that assessed high sugar symbol labels. Three assessed health star ratings and one assessed daily intake guide labels, but none revealed an effect on food purchases compared with the control. CONCLUSIONS Findings on the effectiveness of FOP nutrition labels in 'nudging' consumers toward healthier food purchases remain mixed and inconclusive. Future studies should examine other types of FOP labels beside the traffic lights labels and explore the different effects by consumer affordability, population subgroup, and shopping environment.
Collapse
Affiliation(s)
- R An
- Brown School, Washington University, St. Louis, MO, 63130, USA
| | - Y Shi
- School of Medicine, University of California, La Jolla, San Diego, CA, 92093, USA
| | - J Shen
- Department of Physical Education, China University of Geosciences (Beijing), Beijing, 100083, China
| | - T Bullard
- Department of Kinesiology and Community Health, University of Illinois, Champaign, IL, 61801, USA
| | - G Liu
- Beijing Normal University, Beijing, 100875, China
| | - Q Yang
- Shanghai University of Science and Technology, Shanghai, 201400, China
| | - N Chen
- Tsinghua University, Beijing, 100084, China
| | - L Cao
- School of Management and Journalism, Shenyang Sport University, Shenyang, Liaoning, 110102, China.
| |
Collapse
|
169
|
Shi Y, Gauer JS, Baker SR, Philippou H, Connell SD, Ariëns RAS. Neutrophils can promote clotting via FXI and impact clot structure via neutrophil extracellular traps in a distinctive manner in vitro. Sci Rep 2021; 11:1718. [PMID: 33462294 PMCID: PMC7814028 DOI: 10.1038/s41598-021-81268-7] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2020] [Accepted: 01/04/2021] [Indexed: 12/23/2022] Open
Abstract
Neutrophils and neutrophil extracellular traps (NETs) have been shown to be involved in coagulation. However, the interactions between neutrophils or NETs and fibrin(ogen) in clots, and the mechanisms behind these interactions are not yet fully understood. In this in vitro study, the role of neutrophils or NETs on clot structure, formation and dissolution was studied with a combination of confocal microscopy, turbidity and permeation experiments. Factor (F)XII, FXI and FVII-deficient plasmas were used to investigate which factors may be involved in the procoagulant effects. We found both neutrophils and NETs promote clotting in plasma without the addition of other coagulation triggers, but not in purified fibrinogen, indicating that other factors mediate the interaction. The procoagulant effects of neutrophils and NETs were also observed in FXII- and FVII-deficient plasma. In FXI-deficient plasma, only the procoagulant effects of NETs were observed, but not of neutrophils. NETs increased the density of clots, particularly in the vicinity of the NETs, while neutrophils-induced clots were less stable and more porous. In conclusion, NETs accelerate clotting and contribute to the formation of a denser, more lysis resistant clot architecture. Neutrophils, or their released mediators, may induce clotting in a different manner to NETs, mediated by FXI.
Collapse
Affiliation(s)
- Y Shi
- LIGHT Laboratories, Discovery and Translational Science Department, Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Clarendon Way, Leeds, LS2 9LU, UK
| | - J S Gauer
- LIGHT Laboratories, Discovery and Translational Science Department, Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Clarendon Way, Leeds, LS2 9LU, UK
| | - S R Baker
- LIGHT Laboratories, Discovery and Translational Science Department, Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Clarendon Way, Leeds, LS2 9LU, UK
- Department of Physics, Wake Forest University, Winston Salem, NC, USA
| | - H Philippou
- LIGHT Laboratories, Discovery and Translational Science Department, Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Clarendon Way, Leeds, LS2 9LU, UK
| | - S D Connell
- The Astbury Centre for Structural Molecular Biology, Molecular & Nanoscale Physics, University of Leeds, Leeds, LS2 9JT, UK
| | - R A S Ariëns
- LIGHT Laboratories, Discovery and Translational Science Department, Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Clarendon Way, Leeds, LS2 9LU, UK.
| |
Collapse
|
170
|
Chen LA, She DY, Liang ZX, Liang LL, Chen RC, Ye F, Li YP, Zhou Y, Chen XH, Fang SF, Lai GX, Hu Q, Xie BS, Yao XJ, Shi Y, Su X, He LX, Zhou JY, Zhong SC, Zhang QL, Xiong SD, Qu JM, Tong ZH, Jiang SJ, Liu J, Xu F, He B, Li ER, Yuan YD, Zhang XY, Sun TY, Liu YN. [A prospective multi-center clinical investigation of HIV-negative pulmonary cryptococcosis in China]. Zhonghua Jie He He Hu Xi Za Zhi 2021; 44:14-27. [PMID: 33412620 DOI: 10.3760/cma.j.cn112147-20200122-00034] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the current status of the diagnosis and treatment of pulmonary cryptococcosis in respiratory medicine and improve the understanding of the clinical characteristics of HIV-negative pulmonary cryptococcosis in China. Methods: A prospective multi-center open cohort study was designed to screen for pulmonary cryptococcosis in the general wards and intensive care units of the Department of Respiratory Diseases in 22 hospitals. The HIV-negative patients with positive cryptococcal etiological diagnosis based on smear culture, antigen detection and histopathology were enrolled in the study. The clinical data of enrolled patients were collected and analyzed. Results: A total of 457 cases of pulmonary cryptococcosis were enrolled, among which 3.28% (15/457) were disseminated infections. The case fatality rate was 0.88% (4/457). The majority of the cases were diagnosed by histopathological examinations (74.40%, 340/457) and cryptococcus antigen detection (37.64%, 172/457). Patients with pulmonary cryptococcosis accounted for 2.04‰ (457/223 748) of the total hospitalized patients in the Department of Respiratory Diseases during the same period, and the ratio was the highest in south and east China. Meanwhile, 70.24% (321/457) of the patients had no underlying diseases, while 87.75% (401/457) were found to have immunocompetent status. Cough and expectoration were the most common clinical symptoms in patients with pulmonary cryptococcosis. However, 25.16% (115/457) of the patients had no clinical symptom or physical signs. In terms of imaging features on pulmonary CT, multiple pulmonary lesions were more common than isolated lesions, and there were more subpleural lesions than perihilar or medial lesions. Morphologically, most of the lesions were middle-sized nodules (1-5 cm) or small-sized nodules (3 mm to 1 cm). The sensitivity of serum cryptococcus antigen test was 71.99% (203/282). Moreover, antigen-positive patients differed from antigen-negative patients in terms of basic immune status, clinical symptoms, imaging features and infection types. Meanwhile, immunocompromised patients differed from immunocompetent patients in terms of clinical symptoms, physical signs, infection-related inflammation indicator levels, imaging features, serum cryptococcus antigen positive rate and prognosis. Conclusions: The majority of cases of HIV-negative pulmonary cryptococcosis in China had no underlying disease or immunocompromised status, and the overrall prognosis was favorable. However, early diagnosis of HIV-negative pulmonary cryptococcosis remains challenging due to the complicated manifestations of the disease.
Collapse
Affiliation(s)
- L A Chen
- Department of Pulmonary and Critical Care Medicine, the First Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - D Y She
- Department of Pulmonary and Critical Care Medicine, the First Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - Z X Liang
- Department of Pulmonary and Critical Care Medicine, the First Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - L L Liang
- Department of Pulmonary and Critical Care Medicine, the First Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - R C Chen
- Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China
| | - F Ye
- Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China
| | - Y P Li
- Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000, China
| | - Y Zhou
- Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000, China
| | - X H Chen
- Department of Pulmonary and Critical Care Medicine, Fuzhou Pulmonary Hospital of Fujian, Fuzhou 350008, China
| | - S F Fang
- Department of Pulmonary and Critical Care Medicine, Fuzhou Pulmonary Hospital of Fujian, Fuzhou 350008, China
| | - G X Lai
- Department of Pulmonary and Critical Care Medicine, 900 Hospital of the Joint Logistics Team Support Force,Fuzhou 350025, China
| | - Q Hu
- Department of Pulmonary and Critical Care Medicine, 900 Hospital of the Joint Logistics Team Support Force,Fuzhou 350025, China
| | - B S Xie
- Department of Pulmonary and Critical Care Medicine, Fujian Provincial Hospital,Fuzhou 350001, China
| | - X J Yao
- Department of Pulmonary and Critical Care Medicine, Fujian Provincial Hospital,Fuzhou 350001, China
| | - Y Shi
- Department of Pulmonary and Critical Care Medicine, the General Hospital of Eastern Theater Command;,Nanjing 210002, China
| | - X Su
- Department of Pulmonary and Critical Care Medicine, the General Hospital of Eastern Theater Command;,Nanjing 210002, China
| | - L X He
- Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University,Shanghai 200032, China
| | - J Y Zhou
- Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
| | - S C Zhong
- Department of Pulmonary and Critical Care Medicine, Longyan First Hospital,Longyan 364000, China
| | - Q L Zhang
- Department of Neurology Medicine, Jiangxi Chest Hospital,Nanchang 330006, China
| | - S D Xiong
- Department of Pulmonary and Critical Care Medicine, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
| | - J M Qu
- Department of Pulmonary and Critical Care Medicine, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China
| | - Z H Tong
- Department of Pulmonary and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University,Beijing 100020, China
| | - S J Jiang
- Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital,Jinan 250021, China
| | - J Liu
- Department of Pulmonary and Critical Care Medicine, the Second Hospital of Jilin University, Changchun 130041, China
| | - F Xu
- Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Nanchang University,Nanchang 330006, China
| | - B He
- Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital,Beijing 100191, China
| | - E R Li
- Department of Pulmonary and Critical Care Medicine, the First Hospital of China Medical University,Shenyang 110001, China
| | - Y D Yuan
- Department of Pulmonary and Critical Care Medicine, the Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
| | - X Y Zhang
- Department of Pulmonary and Critical Care Medicine, Guzhou Provincial People's Hospital,Guiyang 550002, China
| | - T Y Sun
- Department of Pulmonary and Critical Care Medicine, Beijing Hospital,Beijing 100730, China
| | - Y N Liu
- Department of Pulmonary and Critical Care Medicine, the First Medical Center of General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| |
Collapse
|
171
|
Luo L, Dang Y, Shi Y, Zhao P, Zhang Y, Zhang K. 64 SIN3 transcription regulator family member A regulates porcine early embryonic development by modulating CCNB1 expression. Reprod Fertil Dev 2021. [DOI: 10.1071/rdv33n2ab64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
SIN3 transcription regulator family member A (SIN3A) is the central scaffold protein of the SIN3/HDAC (histone deacetylase) transcriptional repressor complex. We previously found that SIN3A participates in the mouse pre-implantation development by finetuning HDAC1 expression. However, it remains unresolved whether this functional significance of SIN3A is conserved in other mammals. The objective of this work was thus to characterise the expression profiles and the functional role of SIN3A in pre-implantation development using non-rodent animal models. RNA sequencing results show that a large amount of SIN3A mRNA is present in oocytes and early embryos before embryonic genome activation and a low amount thereafter, suggesting a maternal origin of SIN3A in all species examined. Interestingly, immunofluorescence data show that SIN3A protein level peaks at the 4-cell stage in pigs compared with the morula stage in cattle, suggesting a differential role of SIN3A among species. To explore the function of SIN3A in early embryonic development, we used a short interfering (si)RNA-mediated knockdown approach in porcine parthenogenetic activated (PA) embryos. Immunocytochemical analysis showed that SIN3A levels were diminished ∼80% compared with nonspecific siRNA (NC) injected control (n=3). To monitor the developmental potential of embryo depleted of SIN3A, we injected SIN3A-siRNA into MII stage oocytes, followed by parthenogenetic activation, and percent cleavage and blastocyst formation were recorded. We found that SIN3A knockdown (KD) did not affect the cleavage rate (NC vs. KD, 83.63±3.63% vs. 80.08±4.66%, n=5), but significantly reduced blastocyst rate compared with the NC group (NC vs. KD, 36.64±4.28% vs. 6.33±3.12%, n=5). Specifically, SIN3A depletion in early embryos causes developmental arrest at 2-cell stage in pigs but does not affect early embryonic development in bovines. In contrast with mouse data, SIN3A depletion results in only a slight decrease and even no difference in HDAC1 expression in porcine and bovine early embryos, respectively. In addition, HDAC1 knockdown does not cause 2-cell block but leads to a reduced blastocyst rate, suggesting that the effect of SIN3A depletion on porcine early embryos is independent of HDAC1. RNA-Seq analysis was used to compare the global transcript content between NC and KD 2-cell embryos. A total of 23 genes (14 upregulated and 9 downregulated) had undergone significant changes. Interestingly, cyclin B1 (CCNB1) ranked second among downregulated genes. To test whether knockdown of CCNB1 would display a similar phenotype in porcine early embryos, we injected CCNB1-siRNA into pronuclear stage. CCNB1 KD resulted in a similar phenotype as SIN3A depletion. Injection of exogenous CCNB1 mRNA into SIN3A-depleted embryos could partly rescue embryonic development. In conclusion, our results indicate SIN3A plays an essential role in porcine early embryonic development, probably involving the regulation of CCNB1 expression.
This work was funded by National Natural Science Foundation of China, the Anhui Provincial Natural Science Foundation and China Postdoctoral Science Foundation.
Collapse
|
172
|
Shi Y, Wu L, Yu X, Xing P, Zhou J, Wang A, Shi J, Hu Y, Wang Z, An G, Fang Y, Sun S, Zhou C, Wang C, Ye F, Li X, Wang J, Wang M, Liu Y, Zhao Y. RETRACTED: ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC). Ann Oncol 2020; 31 Suppl 7:S1428. [PMID: 33517977 DOI: 10.1016/j.annonc.2020.10.517] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article was retracted at the request of the authors. The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.
Collapse
Affiliation(s)
- Y Shi
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - L Wu
- Department II of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China
| | - X Yu
- Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China
| | - P Xing
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - J Zhou
- Department of Respiratory Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
| | - A Wang
- The Third Department of Chemotherapy, Weihai Municipal Hospital, Weihai, China
| | - J Shi
- Department of Oncology, Linyi Cancer Hospital, Linyi, China
| | - Y Hu
- Medical Oncology, Chinese People's Liberation Army General Hospital, Beijing, China
| | - Z Wang
- Department I of Thoracic Oncology, Peking University Cancer Hospital & Institute, Beijing, China
| | - G An
- Department of Oncology, Beijing Chao-Yang Hospital, Beijing, China
| | - Y Fang
- Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China
| | - S Sun
- Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou Medical University, Xuzhou, China
| | - C Zhou
- Department of Oncology, Shanghai Pulmonary Hospital, Shanghai, China
| | - C Wang
- Medical Oncology, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin, China
| | - F Ye
- Cancer Hospital, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Teaching Hospital of Fujian Medical University, Department of Medical Oncology, Xiamen, China
| | - X Li
- Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Wang
- Oncology Department, Affiliated Hospital of Jining Medical University, Jining, China
| | - M Wang
- Department of Respiratory Medicine, Peking Union Medical College Hospital, Beijing, China
| | - Y Liu
- Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China
| | - Y Zhao
- Department of Internal Medicine, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
| |
Collapse
|
173
|
Ruan Y, Shi Y, Guo YF, Sun SY, Huang ZZ, Wang YZ, Zheng Y, Wu F. [Association between grip strength, rapid gait speed and cognition in people aged 50 and above in Shanghai during 2009-2010]. Zhonghua Yu Fang Yi Xue Za Zhi 2020; 54:1414-1420. [PMID: 33333660 DOI: 10.3760/cma.j.cn112150-20200714-01003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the association between grip strength, rapid gait speed and cognition in people aged 50 and above in Shanghai. Methods: Cross-sectional data was collected from the World Health Organization (WHO) study on global ageing and adult health (SAGE) wave 1 (2009-2010). A questionnaire survey was conducted among 8 643 participants aged 50 years old and above selected by using multistage random cluster sampling strategies in Shanghai. Factor analysis was applied to evaluate and generate cognitive function overall score.Association between grip strength, rapid gait speed and cognition was examined by a two-level hierarchical linear model. Results: A total of 8 175 participants were included in this study, who were (62.9±9.7) years old, including 3 782 (46.3%) males. The average grip strength and rapid gait speed of participants were (27.46±12.01) kg and (1.44±0.43) m/s respectively. The average scores of verbal recall (VR), verbal fluency (VF), forward digit span (FDS), backward digit span (BDS) and total cognitive scores were (5.72±0.09), (12.67±0.35), (6.84±0.10), (4.32±0.14) and (60.50±0.95) respectively. Grip strength was positively associated with VR, VF, FDS, BDS and overall cognition (standardized β=0.036, 0.079, 0.042, 0.046 and 0.043 respectively, P<0.05), and rapid gait speed was also positively associated with VR, VF and overall cognition (standardized β=0.040, 0.031, 0.039 respectively, P<0.05) after adjusted for age, sex, residence, education level, marital status, household income, co-morbidity of chronic conditions, BMI, drinking, smoking, fruits, vegetables intake and physical activities. Conclusion: Grip strength and rapid gait speed are both positively associated with cognitive function of people aged 50 and above, which would be indicators to evaluate their cognition.
Collapse
Affiliation(s)
- Y Ruan
- Division of Chronic Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - Y Shi
- Division of Chronic Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - Y F Guo
- Division of Chronic Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - S Y Sun
- Division of Chronic Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - Z Z Huang
- Division of Chronic Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - Y Z Wang
- Division of Chronic Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - Y Zheng
- Division of Chronic Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - F Wu
- Office for Shanghai Medical College, Fudan University, Shanghai 200032, China
| |
Collapse
|
174
|
Sun J, Shi Y, Du Y, Wang Z, Liu Z, Wang H, Zhao G, Ma Y, Zheng M. Rapid Detection of Diarrheagenic Escherichia coli by a New Multiplex Real-Time Quantitative PCR Assay. APPL BIOCHEM MICRO+ 2020. [DOI: 10.1134/s0003683820060174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
175
|
Zhou H, Shi Y, Liu C, Xu L. Laparoscopic posterior pelvic exenteration for invasive endometriosis of the rectum - a video vignette. Colorectal Dis 2020; 22:2338. [PMID: 32673444 DOI: 10.1111/codi.15272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/09/2020] [Accepted: 07/05/2020] [Indexed: 02/08/2023]
Affiliation(s)
- H Zhou
- Department of Gastrointestinal Surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - Y Shi
- Department of Gynecologic Oncology Center, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - C Liu
- Department of Gastrointestinal Surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| | - L Xu
- Department of Gastrointestinal Surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
| |
Collapse
|
176
|
Sun H, Yang J, Shi Y, Wang Y, Li C, Zhu M. Hydrogen sulfide in the nucleus tractus solitarii regulates gastric acid secretion in rats. J Physiol Pharmacol 2020; 71. [PMID: 33214338 DOI: 10.26402/jpp.2020.4.05] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Received: 07/25/2020] [Accepted: 08/29/2020] [Indexed: 11/03/2022]
Abstract
Hydrogen sulfide (H2S) is a neuromodulator in the central nervous system. The physiological function of H2S in the nucleus tractus solitarii (NTS) has rarely been reported. This research aimed to explore the role of H2S in regulating gastric functions. Wistar rats were randomly assigned to sodium hydrosulfide (NaHS; 4 and 8 nmol) groups, physiological saline (PS) group, capsazepine (10 pmol) + NaHS (4 nmol) group, L703606 (4 nmol) + NaHS (4 nmol) group, and pyrrolidine dithiocarbamate (4 nmol) + NaHS (4 nmol) group. The pH values of gastric acid were measured using a pH meter pre- and post-injection. It was found that the microinjetion of NaHS (4 and 8 nmol), an exogenous H2S donor, into the NTS (n = 6) remarkably decreased the pH values of gastric juice. The inductive effect of NaHS on gastric juice production could be suppressed by capsazepine (a transient receptor potential vanilloid 1 antagonist), L703606 (a NK1 receptor antagonist) and pyrrolidine dithiocarbamate (a nuclear fator-κB inhibitor). However, the same amount of PS did not induce any significant change in the pH value of gastric acid (P > 0.05). The findings of this study revealed that NaHS within the NTS remarkably promoted gastric acid secretion via the activation of TRPV1 channels and nuclear factor-κB-dependent mechanism in rats.
Collapse
Affiliation(s)
- H Sun
- School of Life Science, Qilu Normal University, No.2, Zhangqiu 250200, Jinan, P.R. China.
| | - J Yang
- School of Life Science, Qilu Normal University, No.2, Zhangqiu 250200, Jinan, P.R. China
| | - Y Shi
- School of Life Science, Qilu Normal University, No.2, Zhangqiu 250200, Jinan, P.R. China
| | - Y Wang
- School of Life Science, Qilu Normal University, No.2, Zhangqiu 250200, Jinan, P.R. China
| | - C Li
- School of Life Science, Qilu Normal University, No.2, Zhangqiu 250200, Jinan, P.R. China
| | - M Zhu
- School of Life Science, Qilu Normal University, No.2, Zhangqiu 250200, Jinan, P.R. China
| |
Collapse
|
177
|
Loefroth E, Hughes M, Shi Y, Wang Y, Proudfoot C, Di Domenico M, Modgill V, Schlienger R, Studer R. Patient and clinical characteristics of heart failure patients concomitantly prescribed SGLT2 inhibitors and sacubitril/valsartan, a database cohort study using the Optum electronic health record data. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and purpose
Sacubitril/valsartan (sac/val), an angiotensin receptor neprilysin inhibitor, reduces the risk for cardiovascular (CV) death or hospitalization for heart failure (HF) in HF with reduced ejection fraction (HFrEF). Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are approved in patients with type 2 diabetes (T2D) and have shown to reduce the CV risk in T2D patients with established CV or at risk of CV disease. The SGLT2i dapagliflozin has shown to improve outcomes in patients with chronic HFrEF, with or without T2D, when used in addition to standard of care including sac/val. As the use of SGLT2i in HF evolves, and given the large overlap of HF and T2D populations, it is of interest to understand the population with concomitant use of sac/val and SGLT2i. This study describes the clinical characteristics of patients treated concomitantly with sac/val and SGLT2i or concomitantly with sac/val and dipeptidyl peptidase-4 inhibitors (DPP4i) or glucagon-like peptide-1 receptor agonists (GLP1), two comparable second line anti-diabetic drug classes.
Methods
This retrospective non-interventional study describes two mutually exclusive adult patient cohorts diagnosed with HF and T2D concomitantly prescribed sac/val and SGLT2i (cohort 1), or concomitantly prescribed sac/val and DDP4i/GLP1 (cohort 2). The index date was defined as the first date of concomitant use with prescriptions overlapping a minimum of 21 days. Patients were identified any time between 1/1/2015 and 30/6/2019 in the Optum® de-identified electronic health record (EHR) data from providers across the continuum of care.
Results
2.3 million HF patients were identified, and 41.6% had a T2D diagnosis. 560 patients were concomitantly prescribed sac/val and SGLT2i (cohort 1) and 1,566 concomitantly sac/val and DDP4/GLP1 (cohort 2). There was a higher proportion of females in cohort 2 (35.0% vs 27.9%). Mean age was higher in cohort 2 (66.4 vs 61.4 years). The mean estimated glomerular filtration rate was 85.93 (SD 23.43) ml/min/1.73m2 (cohort 1) and 72.10 (Std. 27.11) ml/min/1.73m2 (cohort 2). The proportion of stage 3 CKD (<60 to >30 ml/min/1.73m2) was 11.8% (cohort 1) and 24.4% (cohort 2). Mean systolic blood pressure was similar, 120 mmHg (cohort 1) and 122 mmHg (cohort 2). Mean hemoglobin was 13.60 g/dl (cohort 1) and 12.43 g/dl (cohort 2). Median (IQR) NT-proBNP differed between the two cohorts, 914 (2154) pg/ml (cohort 1) and 2,290 (5,301) pg/ml (cohort 2) but with complete values available in only 17.7 and 19.0% of each cohort.
Conclusions
This descriptive analysis of concomitant prescription of sac/val and SGLT2i or DPP4/GLP1 highlights differences in the clinical characteristics between the two cohorts. The patients treated with sac/val and SGLT2i start with a more favorable clinical profile compared to the patients treated with sac/val and DPP4/GLP1. Further analyses are needed to determine if these differences are driven by age, gender or other factors.
Funding Acknowledgement
Type of funding source: Private company. Main funding source(s): Novartis Pharma AG
Collapse
Affiliation(s)
| | - M Hughes
- Novartis Ireland Limited, Dublin, Ireland
| | - Y Shi
- Novartis Pharmaceuticals Corporation, East Hanover, United States of America
| | - Y Wang
- Novartis Pharmaceuticals Corporation, East Hanover, United States of America
| | | | | | - V Modgill
- Novartis Pharma AG, Basel, Switzerland
| | | | - R Studer
- Novartis Pharma AG, Basel, Switzerland
| |
Collapse
|
178
|
McClung MR, Bolognese MA, Brown JP, Reginster JY, Langdahl BL, Maddox J, Shi Y, Rojeski M, Meisner PD, Grauer A. A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab. Osteoporos Int 2020; 31:2231-2241. [PMID: 32623487 PMCID: PMC7560921 DOI: 10.1007/s00198-020-05502-0] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/11/2019] [Accepted: 06/08/2020] [Indexed: 01/02/2023]
Abstract
UNLABELLED This phase 2 study evaluated the efficacy and safety of transitioning to zoledronate following romosozumab treatment in postmenopausal women with low bone mass. A single dose of 5 mg zoledronate generally maintained the robust BMD gains accrued with romosozumab treatment and was well tolerated. INTRODUCTION Follow-on therapy with an antiresorptive agent is necessary to maintain the skeletal benefits of romosozumab therapy. We evaluated the use of zoledronate following romosozumab treatment. METHODS This phase 2, dose-finding study enrolled postmenopausal women with low bone mineral density (BMD). Subjects who received various romosozumab doses or placebo from months 0-24 were rerandomized to denosumab (60 mg SC Q6M) or placebo for 12 months, followed by open-label romosozumab (210 mg QM) for 12 months. At month 48, subjects who had received active treatment for 48 months were assigned to no further active treatment and all other subjects were assigned to zoledronate 5 mg IV. Efficacy (BMD, P1NP, and β-CTX) and safety were evaluated for 24 months, up to month 72. RESULTS A total of 141 subjects entered the month 48-72 period, with 51 in the no further active treatment group and 90 in the zoledronate group. In subjects receiving no further active treatment, lumbar spine (LS) BMD decreased by 10.8% from months 48-72 but remained 4.2% above the original baseline. In subjects receiving zoledronate, LS BMD was maintained (percentage changes: - 0.8% from months 48-72; 12.8% from months 0-72). Similar patterns were observed for proximal femur BMD in both groups. With no further active treatment, P1NP and β-CTX decreased but remained above baseline at month 72. Following zoledronate, P1NP and β-CTX levels initially decreased but approached baseline by month 72. No new safety signals were observed. CONCLUSION A zoledronate follow-on regimen can maintain robust BMD gains achieved with romosozumab treatment.
Collapse
Affiliation(s)
- M R McClung
- Oregon Osteoporosis Center, 2881 NW Cumberland Road, Portland, OR 97210, USA.
- Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia.
| | | | - J P Brown
- Laval University and CHU de Québec (CHUL) Research Centre, Québec City, QC, Canada
| | - J-Y Reginster
- University of Liège, Liège, Belgium
- King Saud University, Riyadh, Kingdom of Saudi Arabia
| | | | - J Maddox
- Amgen Inc., Thousand Oaks, CA, USA
| | - Y Shi
- Amgen Inc., Thousand Oaks, CA, USA
| | | | | | - A Grauer
- Amgen Inc., Thousand Oaks, CA, USA
| |
Collapse
|
179
|
Abstract
Brain tumors have high morbidity and may lead to highly lethal cancer. In clinics, accurate segmentation of tumors is the means for diagnosis and determination of subsequent treatment options. Due to the irregularity and blurring of tumor boundaries, accurately segmenting the tumor lesions has received extensive attention in medical image analysis. In view of this situation, this paper proposed a brain tumor segmentation method based on generative adversarial networks (GANs). The GAN architecture consists of a densely connected three-dimensional (3D) U-Net used for segmentation and a classification network for discrimination, both of which use 3D convolutions to fuse multi-dimensional context information. The densely connected 3D U-Net model introduces a dense connection to accelerate network convergence, extracting more detailed information. The adversarial training makes the distribution of segmentation results closer to that of labeled data, which enables the network to segment some unexpected small tumor subregions. Alternately, train two networks and finally achieve a highly accurate classification of each voxel. The experiments conducted on BraTS2017 brain tumor MRI dataset show that the proposed method has higher accuracy in brain tumor segmentation.
Collapse
Affiliation(s)
- Yitong Li
- Institute of Signal and Image Processing, Beijing Institute of Technology, 5 South Zhongguancun Street, Haidian District Beijing, P. R. China
| | - Yue Chen
- Institute of Signal and Image Processing, Beijing Institute of Technology, 5 South Zhongguancun Street, Haidian District Beijing, P. R. China
| | - Y. Shi
- Institute of Signal and Image Processing, Beijing Institute of Technology, 5 South Zhongguancun Street, Haidian District Beijing, P. R. China
| |
Collapse
|
180
|
Li C, Liu SM, Zheng L, Huang MW, Shi Y, Lv XM, Zhang JG, Peng X, Zhang J. Comparison of outcomes using radiotherapy or brachytherapy after resection of primary adenoid cystic carcinoma in oral and maxillofacial regions. Brachytherapy 2020; 20:171-177. [PMID: 33069597 DOI: 10.1016/j.brachy.2020.08.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Revised: 06/23/2020] [Accepted: 08/19/2020] [Indexed: 11/29/2022]
Abstract
We wished to investigate the outcome of surgery combined with external-beam radiotherapy (EBRT) or brachytherapy (125I seeds) for the treatment of primary adenoid cystic carcinoma (ACC) of the oral and maxillofacial region. Data of patients with primary ACC were reviewed retrospectively. Patients were divided into EBRT and brachytherapy groups. Wide tumor excision was done to achieve negative margins. Standard radiotherapy in the EBRT group was 60 Gy. A treatment-planning system was used to create implantation plans with a prescribed dose of 60-120 Gy and 125I seeds were implanted postoperatively. Kaplan-Meier method and log-rank tests were used to analyze local control and survival. The median duration of followup was 66.1 and 46.8 months for the EBRT group and brachytherapy group, respectively. There was no significant difference in local control, control of metastasis to regional lymph nodes, or control of distant metastasis between the two groups. There was no significant difference in overall survival, disease-specific survival, or disease-free survival in the two groups at 3 years and 5 years. The prevalence of complications in the brachytherapy group was lower than that in the EBRT group. Both methods elicited good treatment effects, but the prevalence of adverse events was lower in the brachytherapy group.
Collapse
Affiliation(s)
- C Li
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
| | - S M Liu
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
| | - L Zheng
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
| | - M W Huang
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
| | - Y Shi
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
| | - X M Lv
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
| | - J G Zhang
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
| | - X Peng
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China
| | - J Zhang
- Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing, China.
| |
Collapse
|
181
|
Shi Y, Jones W, Beatty W, Tan Q, Mecham RP, Kumra H, Reinhardt DP, Gibson MA, Reilly MA, Rodriguez J, Bassnett S. Latent-transforming growth factor beta-binding protein-2 (LTBP-2) is required for longevity but not for development of zonular fibers. Matrix Biol 2020; 95:15-31. [PMID: 33039488 DOI: 10.1016/j.matbio.2020.10.002] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Revised: 10/04/2020] [Accepted: 10/04/2020] [Indexed: 01/06/2023]
Abstract
Latent-transforming growth factor beta-binding protein 2 (LTBP-2) is a major component of arterial and lung tissue and of the ciliary zonule, the system of extracellular fibers that centers and suspends the lens in the eye. LTBP-2 has been implicated previously in the development of extracellular microfibrils, although its exact role remains unclear. Here, we analyzed the three-dimensional structure of the ciliary zonule in wild type mice and used a knockout model to test the contribution of LTBP-2 to zonule structure and mechanical properties. In wild types, zonular fibers had diameters of 0.5-1.0 micrometers, with an outer layer of fibrillin-1-rich microfibrils and a core of fibrillin-2-rich microfibrils. LTBP-2 was present in both layers. The absence of LTBP-2 did not affect the number of fibers, their diameters, nor their coaxial organization. However, by two months of age, LTBP-2-depleted fibers began to rupture, and by six months, a fully penetrant ectopia lentis phenotype was present, as confirmed by in vivo imaging. To determine whether the seemingly normal fibers of young mice were compromised mechanically, we compared zonule stress/strain relationships of wild type and LTBP-2-deficient mice and developed a quasi-linear viscoelastic engineering model to analyze the resulting data. In the absence of LTBP-2, the ultimate tensile strength of the zonule was reduced by about 50%, and the viscoelastic behavior of the fibers was altered significantly. We developed a harmonic oscillator model to calculate the forces generated during saccadic eye movement. Model simulations suggested that mutant fibers are prone to failure during rapid rotation of the eyeball. Together, these data indicate that LTBP-2 is necessary for the strength and longevity of zonular fibers, but not necessarily for their formation.
Collapse
Affiliation(s)
- Y Shi
- Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, 660 S. Euclid Ave, Box 8096, St. Louis, MO 63110, USA
| | - W Jones
- Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, 660 S. Euclid Ave, Box 8096, St. Louis, MO 63110, USA
| | - W Beatty
- Department of Molecular Microbiology, Washington University, St. Louis, MO, USA
| | - Q Tan
- Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, 660 S. Euclid Ave, Box 8096, St. Louis, MO 63110, USA
| | - R P Mecham
- Department of Cell Biology & Physiology, Washington University, St. Louis, MO, USA
| | - H Kumra
- Department of Anatomy & Cell Biology, and Faculty of Dentistry, McGill University, Montreal, Quebec, Canada
| | - D P Reinhardt
- Department of Anatomy & Cell Biology, and Faculty of Dentistry, McGill University, Montreal, Quebec, Canada
| | - M A Gibson
- Department of Medical Sciences, Adelaide Medical School, University of Adelaide, Adelaide, Australia
| | - M A Reilly
- Department of Biomedical Engineering, The Ohio State University, Columbus, OH, USA; Department of Ophthalmology and Visual Science, The Ohio State University, Columbus, OH, USA
| | - J Rodriguez
- Department of Basic Sciences, St. Louis College of Pharmacy, St. Louis, MO, USA
| | - S Bassnett
- Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, 660 S. Euclid Ave, Box 8096, St. Louis, MO 63110, USA; Department of Cell Biology & Physiology, Washington University, St. Louis, MO, USA.
| |
Collapse
|
182
|
Fan Y, He Y, Shi Y. [Research progress in the application of high-frequency oscillatory ventilation combined with volume-guarantee in premature infants]. Zhonghua Er Ke Za Zhi 2020; 58:850-853. [PMID: 32987469 DOI: 10.3760/cma.j.cn112140-20200418-00401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Y Fan
- Department of Neonatology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Child Infection and Immunity, Chongqing 400014, China
| | - Y He
- Department of Neonatology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Child Infection and Immunity, Chongqing 400014, China
| | - Y Shi
- Department of Neonatology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Child Infection and Immunity, Chongqing 400014, China
| |
Collapse
|
183
|
Yang DN, Wu JH, Geng L, Cao LJ, Zhang QJ, Luo JQ, Kallen A, Hou ZH, Qian WP, Shi Y, Xia X. Efficacy of intrauterine perfusion of peripheral blood mononuclear cells (PBMC) for infertile women before embryo transfer: meta-analysis. J OBSTET GYNAECOL 2020; 40:961-968. [PMID: 31791175 DOI: 10.1080/01443615.2019.1673711] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
This meta-analysis was intended to evaluate the effects of intrauterine perfusion of peripheral blood mononuclear cells (PBMC) on the pregnancy outcomes including clinical pregnancy rates, embryo implantation rates, live birth rates and miscarriage rates of infertile women who were undergoing in vitro fertilisation (IVF) treatment. By searching Pubmed, Embase database, five articles meeting the inclusion criteria were included, and 1173 women were enrolled (intrauterine PBMC group: n = 514; NO-PBMC group: n = 659). For the entire IVF/ICSI population and one or two embryo transfer failure patients, there was no significant difference in endometrial thickness, embryo implantation rates, live birth rates, and miscarriage rates between the PBMC group and NO-PBMC group. Although the clinical pregnancy rates of the PBMC group were higher than that of the NO-PBMC group, the confidence interval was close to the line of unity. As for the patients with three or more implantation failures, the clinical pregnancy rates, embryo implantation rates and live birth rates were much higher in the PBMC group than that of the NO-PBMC group. In summary, current evidence suggests that intrauterine perfusion of PBMC can significantly improve pregnancy outcomes in patients who have three or more implantation failures.Impact statementWhat is already known on this subject? An increasing number of studies have shown that immune cells play an important role in embryo transfer. There is no reliable evidence to confirm the clinical efficacy of intrauterine perfusion of PBMC.What do the results of this study add? The current evidence suggests that intrauterine perfusion of PBMC can significantly improve pregnancy outcomes in patients who have three or more implantation failures.What are the implications of these findings for clinical practice and/or further research? To the best of our knowledge, this meta-analysis is the first to evaluate the effect of intrauterine perfusion of PBMC on pregnancy outcomes before embryo transfer. Our study indicated that intrauterine perfusion of PBMC significantly increased clinical pregnancy rates, embryo implantation rates, and live birth rates in patients who failed more than three implants.
Collapse
Affiliation(s)
- D N Yang
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
- Shantou University Medical College, Shantou, Guangdong, China
| | - J H Wu
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
- Shantou University Medical College, Shantou, Guangdong, China
| | - L Geng
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
- Shantou University Medical College, Shantou, Guangdong, China
| | - L J Cao
- Department of Gynecology & Obstetrics, Nanshan People's Hospital, Nan Shan District, Shenzhen, Guangdong, China
| | - Q J Zhang
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
- Shantou University Medical College, Shantou, Guangdong, China
| | - J Q Luo
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
- Shantou University Medical College, Shantou, Guangdong, China
| | - Amanda Kallen
- Division of Reproductive Endocrinology & Infertility, Department of Obstetrics, Gynecology, & Reproductive Sciences, Yale University School of Medicine, CT USA
| | - Z H Hou
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
- Shantou University Medical College, Shantou, Guangdong, China
| | - W P Qian
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - Y Shi
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - X Xia
- Center for Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| |
Collapse
|
184
|
Wei F, Shi Y, Li J, Zhang Y. Multi-strategy synergy-based backtracking search optimization algorithm. Soft comput 2020. [DOI: 10.1007/s00500-020-05225-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
185
|
Josse M, Coulis G, Bergeron A, Shi Y, Labbé D, Tremblay M, Vergely-Vandriesse C, Karsenty G, Boivin B. Characterization of protein expression of thyroid-responsive genes in cardiomyocyte PTP1B knockout mice in cardiac hypertrophy. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2020.03.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
186
|
Xie B, Yan WJ, Meng XY, Miao XG, Yu F, Dong M, Shi Y, Xiang P, Ma CL, Wen D. [Influence of Halogenated Hydroxyl-Alkanes Inhalation Anesthetic on the Determination of Ethanol Content in Blood]. Fa Yi Xue Za Zhi 2020; 36:682-687. [PMID: 33295171 DOI: 10.12116/j.issn.1004-5619.2020.05.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 12/04/2019] [Indexed: 06/12/2023]
Abstract
Objective To study the influence of halogenated hydroxyl-alkanes inhalation anesthetic on the determination of ethanol content in blood. Methods Halogenated hydroxyl-alkanes were analyzed by headspace gas chromatography with double column confirmatory detection method. The influence of halogenated hydroxyl-alkanes on determination of ethanol content in blood sample by headspace gas chromatography was explored under the different detection conditions of KB-BAC1/ KB-BAC2 and J&W DB-ALC1/DB-ALC2 gas chromatographic column. Results The retention time of sevoflurane and enflurane was similar to that of ethanol and tert butanol respectively when using the J&W DB-ALC1/DB-ALC2 gas chromatographic column, and interfered with the detection of ethanol content in blood; only J&W DB-ALC1 gas chromatographic column can separate the sevoflurane and ethanol components, so as to eliminate their influence on the detection of ethanol content in blood. When using KB-BAC1/KB-BAC2 gas chromatographic column, the retention time of sevoflurane, isoflurane and ethanol is similar, especially that of sevoflurane and ethanol, and sevoflurane obviously interferes with the determination of ethanol content in blood. Conclusion Halogenated hydroxy-alkanes interfere with determination of ethanol content in blood by headspace gas chromatography. The interference can be discriminated effectively by choosing the suitable chromatographic column and double column confirmatory detection.
Collapse
Affiliation(s)
- B Xie
- Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - W J Yan
- Huanghua Forensic Identification Center, Huanghua 061100, Hebei Province, China
| | - X Y Meng
- Shijiazhuang Public Transportation Administration Bureau, Shijiazhuang 050091, China
| | - X G Miao
- Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - F Yu
- Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - M Dong
- Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - Y Shi
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China
| | - P Xiang
- Shanghai Key Laboratory of Forensic Medicine, Key Laboratory of Forensic Science, Ministry of Justice, Shanghai Forensic Service Platform, Academy of Forensic Science, Shanghai 200063, China
| | - C L Ma
- Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - D Wen
- Collaborative Innovation Center of Forensic Medical Molecular Identification, Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| |
Collapse
|
187
|
Guo YH, Xu DB, Jiang QC, Shi Y, Zhou FL, Yuan QQ. [Comprehensive benefits of agroforestry snail control forests in Eryuan County, Yunnan Province]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2020; 32:384-388. [PMID: 32935513 DOI: 10.16250/j.32.1374.2019029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To investigate the efficiency of various agroforestry systems for snail control in plateau hilly schistosomiasis-endemic areas of Yunnan Province, so as to provide insights into the construction of agroforestry schistosomiasis control projects in plateau hilly regions. METHODS The pilot areas of snail control forests with various agroforestry systems were built in snail-breeding farmlands in Eryuan County, Yunnan Province in 2010, and the economic benefits and snail control effect were investigated in 2018. In addition, a fuzzy comprehensive evaluation model was created to screen the agroforestry system with high comprehensive benefits. RESULTS A total of 14 types of pilot areas of snail control forests with various agroforestry systems were built. Economic benefit analysis showed that the"walnut + garlic"pattern had the best economic benefit, with annual economic benefits of 270 000 Yuan/hm2, followed by the"walnut + chili"pattern (annual economic benefits of 120 000 Yuan/hm2) and the "walnut + vegetables"pattern (annual economic benefits of 105 000 Yuan/hm2). No snails were detected in 8 types of the agroforestry systems, including the"walnut + chili"pattern, the"walnut + tobacco"pattern and the"walnut + garlic"pattern; however, there were snail found with various densities in other types of systems. Fuzzy comprehensive evaluation showed that the"walnut + garlic"pattern had the best comprehensive control effect, followed by the"walnut + chili"pattern and the"walnut + tobacco" pattern, while the pure grassland pattern showed no effect on snail control. CONCLUSIONS The agroforestry system is a preferential approach of forestry schistosomiasis control in plateau hilly schistosomiasis-endemic areas, which not only achieves snail control effects, but also promotes economic development and ecological construction in poor hilly areas.
Collapse
Affiliation(s)
- Y H Guo
- Yunnan Academy of Forestry and Grassland, Kunming Yunnan 650201, China
| | - D B Xu
- Yunnan Academy of Forestry and Grassland, Kunming Yunnan 650201, China
| | - Q C Jiang
- Yunnan Academy of Forestry and Grassland, Kunming Yunnan 650201, China
| | - Y Shi
- Yunnan Academy of Forestry and Grassland, Kunming Yunnan 650201, China
| | - F L Zhou
- Yunnan Academy of Forestry and Grassland, Kunming Yunnan 650201, China
| | - Q Q Yuan
- Yunnan Academy of Forestry and Grassland, Kunming Yunnan 650201, China
| |
Collapse
|
188
|
Gao M, Zhang J, Wang JZ, Liu Y, Zhang X, Shi Y. [Effects of hypoxia-pretreated rat adipose-derived mesenchymal stem cells conditioned medium on wound healing of rats with full-thickness defects]. Zhonghua Shao Shang Za Zhi 2020; 36:803-812. [PMID: 32972065 DOI: 10.3760/cma.j.cn501120-20200508-00258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the effects of hypoxia-pretreated rat adipose-derived mesenchymal stem cells (ADSCs) conditioned medium on wound healing of rats with full-thickness defects. Methods: (1) A 6-week-old male Sprague-Dawley rat was sacrificed by cervical dislocation, the bilateral inguinal adipose tissue was collected, the third generation ADSCs were isolated by collagenase digestion method, and the cells morphology was observed. The cells were harvested and divided into adipogenic induction group and osteogenic induction group according to the random number table (the same grouping method below), with 6 wells in each group. The cells in adipogenic induction group were cultured for 14 days to observe adipogenesis, and cells in osteogenic induction group were cultured for 28 days to observe osteogenesis. (2) The third generation ADSCs were collected and divided into normoxic group and hypoxic group. Cells in normoxic group was incubated in normal oxygen incubator with oxygen volume fraction of 21%, and cells in hypoxic group was incubated in low oxygen incubator with oxygen volume fraction of 2% respectively, with 3 samples in each group for each time point. Three samples in normoxic group on 3 h of culture and in hypoxic group on 3, 6, 12, 24, and 48 h of culture were collected for detecting the following indexes. The mRNA expressions of hypoxia inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and peroxisome proliferator-activated receptor γ (PPAR-γ) were detected by real time fluorescent quantitative reverse transcription polymerase chain reaction. The cell culture supernatant in the two groups was collected, centrifuged, and filtered to obtain normoxic conditioned medium (normo-CM ) and hypoxic conditioned medium (hypo-CM). Enzyme linked immunosorbent assay was used to detect content of VEGF, transforming growth factor β (TGF-β), epidermal growth factor (EGF), and insulin-like growth factor (IGF) in conditioned medium. (3) Twenty-seven male Sprague-Dawley rats aged 6-8 weeks were collected and divided into phosphate buffer solution (PBS) group, normo-CM group, and hypo-CM group, with 9 rats in each group. A circular full-thickness skin defect wound with diameter of 1 cm was made on the back of each rat, and the wounds of rats in PBS, normo-CM, and hypo-CM groups were respectively dropped with 50 μL PBS, normo-CM, and hypo-CM. On post injury day (PID) 0, 3, 5, 7, 9, and 11, the gross condition of wound was observed, wound area was measured, and the non-healing rate of wound was calculated. The wound tissue was collected for hematoxylin eosin staining to observe inflammatory reaction of wound on PID 3, 9, and 11 and re-epithelialization of wound on PID 9. Masson staining was used to observe the collagen deposition and analyze collagen volume fraction of wound on PID 11. Data were statistically analyzed with analysis of variance for repeated measurement, one-way analysis of variance, t test, and Bonferroni correction. Results: (1) The isolated cells showed a fusiform, in adherent growth and close arrangement when in low fusion degree. On 14 d of culture, the red lipid droplets stained with oil red O were observed in cells in adipogenic induction group, and on 28 d of culture, the red nodules stained with alizarin red S were observed in cells in osteogenic induction group. The cells were identified as ADSCs. (2) Compared with that in normoxic group, the mRNA expression of HIF-1α was significantly increased at 12 and 24 h of culture (t=5.43, 5.11, P<0.05), the mRNA expression of VEGF was significantly increased at 6 and 12 h of culture (t=3.29, 2.33, P<0.05 or P<0.01), the mRNA expression of bFGF was significantly increased at 12 h of culture (t=12.59, P<0.01) and significantly reduced at 48 h of culture (t=9.34, P<0.01), and the mRNA expression of PPAR-γ was significantly reduced at 3, 12, and 24 h of culture in hypoxic group (t=5.14, 6.56, 4.97, P<0.05). (3) Compared with that in normoxic group, the VEGF content was significantly increased at 3, 6, 12, 24, and 48 h of culture (t=5.74, 12.37, 14.80, 15.70, 34.63, P<0.05 or P<0.01), and the IGF content was significantly increased at 6, 12, 24, and 48 h of culture (t=5.65, 8.06, 20.12, 22.99, P<0.05 or P<0.01), and the content of TGF-β and EGF showed no obvious change at 3, 6, 12, 24, and 48 h of culture in hypoxic group. (4) From PID 0 to 11, the wound of rats in the three groups shrank to varying degrees, with no obvious infection or exudate. On PID 11, the wound area of rats in PBS group was still large, which was larger than that in normo-CM group, and the wound area of rats in hypo-CM group was basically healed. On PID 0, 3, and 5, the non-healing rates of wound of rats in the three groups were similar. On PID 7, the non-healing rates of wound of rats in normo-CM and hypo-CM groups were significantly lower than that in PBS group (t=10.26, 16.03, P<0.05). On PID 9, the non-healing rate of wound of rats in hypo-CM group was significantly lower than that of PBS group and normo-CM group, respectively (t=17.25, 6.89, P<0.05 or P<0.01), and the non-healing rate of wound of rats in normo-CM group was significantly lower than that in PBS group (t=8.81, P<0.05). On PID 11, the non-healing rate of wound of rats in hypo-CM group was (2.4±1.5)%, which was significantly lower than (20.0±5.0)% in PBS group and (7.7±1.7)% in normo-CM group (t= 30.15, 84.80, P<0.05). (5) On PID 3, the infiltration of inflammatory cells in the wound of rats in hypo-CM group was obviously more than those in the other two groups. On PID 9, the infiltration of inflammatory cells in the wound of rats in hypo-CM and normo-CM groups was obviously less than that in PBS group. On PID 11, the infiltration of inflammatory cells in the wound of rats in hypo-CM group was obviously less than those in PBS and normo-CM groups. On PID 9, the length of " epidermal migration tongue" on the wound of rats in hypo-CM group was longer than those of the other two groups, and the epidermis thickness was close to normal skin. On PID 11, compared with those in PBS and normo-CM groups, a large number of collagen deposits with dense structure, neat arrangement, and higher maturity were seen in the wound of rats in hypo-CM group. The wound collagen volume fraction of rats in PBS group was (22.90±1.25)%, which was significantly lower than (31.96±0.14)% in normo-CM group and (56.10±1.50)% in hypo-CM group (t=12.48, 29.43, P<0.05), and the wound collagen volume fraction of rats in normo-CM group was significantly lower than that in hypo-CM group (t=27.73, P<0.05). Conclusions: Hypoxia-pretreated can significantly enhance paracrine effect of rat ADSCs. Hypoxia-pretreated rat ADSC conditioned medium can accelerate the healing of full-thickness skin defect wound in rats by regulating inflammatory cell infiltration, promoting re-epithelialization and collagen deposition in the wound.
Collapse
Affiliation(s)
- M Gao
- Department of Burns and Plastic Surgery, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200001, China
| | - J Zhang
- Department of Burns and Plastic Surgery, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200001, China
| | - J Z Wang
- Department of Burns and Plastic Surgery, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200001, China
| | - Y Liu
- Department of Burns and Plastic Surgery, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200001, China
| | - X Zhang
- Department of Burns and Plastic Surgery, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200001, China
| | - Y Shi
- Department of Burns and Plastic Surgery, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200001, China
| |
Collapse
|
189
|
Han LY, Gao YH, Yu GL, Shi Y, Li WP, Wang ZQ, Li YJ, Jin FG. [The therapeutic effect of carnosine combined with dexamethasone in the lung injury of seawater-drowning]. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43:772-777. [PMID: 32894911 DOI: 10.3760/cma.j.cn112147-20191028-00717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the therapeutic effect of carnosine and dexamethasone in lung injury caused by seawater drowning. Methods: The in vitro experiments with A549 cells were divided into 5 groups: blank control group (C), seawater injury group (S), seawater injury+dexamethasone treatment group (S+D), seawater injury+carnosine treatment group (S+C), seawater injury dexamethasone and carnosine combined therapy(S+D+C) group. The optimal therapeutic dose of drugs for the treatment of seawater drowning lung injury was tested in vitro. Based on the optimal dose, the levels of TNF-α and IL-6 in each group at different time points were detected at the cell level by ELISA. The level of apoptosis was detected by flow cytometry. The in vivo experiments with SD rats were randomly divided into 5 groups (n=8 each): blank control group (RC),seawater drowning injury group (RS),seawater drowning injury+dexamethasone treatment group (RSD),seawater drowning injury+carnosine treatment group (RSC),seawater drowning injury+dexamethasone+carnosine combined treatment group (RSDC). The animal model with seawater inhalation acute lung injury was made by intratracheal infusion (4 ml/kg). The pathological changes of the lungs were observed. The expression of superoxide dismutase (SOD) in each group was detected by Western blot. Results: The results of in vitro experiments showed significant increase of apoptosis after seawater injury. The normal cell rate in group C was 98.3% while the apoptosis rate was 1.7%. The normal cell in group S was 18.8%, and the apoptosis rate was 81% (P<0.01). TNF-α and IL-6 levels in group S increased to 180.25 ng/L and 61.56 ng/L, respectively, which were statistically significant compared with group C (P<0.01). After drug protection, apoptosis was reduced in S+D group, S+C group and S+D+C group, with apoptosis rates of 65.4%, 70.9% and 42.6%, respectively. The contents of TNF-α and IL-6 also decreased in the S+D+C group (P<0.01). The results of in vivo experiments showed obvious lung injury and disordered lung tissue structures in the RS group at 4 h after modeling. There was hemorrhage in the pulmonary interstitium and a large number of inflammatory cells. Results of western blot showed that the expression of SOD increased in the RS group. Compared with RS group, the treatment alleviated acute lung injury and decreased the expression level of SOD in RSD, RSC and RSDC groups (P<0.01). Conclusion: Dexamethasone and carnosine reduced the influence of seawater inhalation on the lung in the rat model. The positive effect of combination of these two drugs on lung injury caused by seawater inhalation was stronger than a single drug.
Collapse
Affiliation(s)
- L Y Han
- Department of Respiratory Disease and Critical Care Medicine, the Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China
| | - Y H Gao
- Department of Respiratory Disease and Critical Care Medicine, the Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China
| | - G L Yu
- Department of Respiratory Disease and Critical Care Medicine, the Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China
| | - Y Shi
- Department of Respiratory Disease and Critical Care Medicine, the Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China
| | - W P Li
- Department of Respiratory Disease and Critical Care Medicine, the Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China
| | - Z Q Wang
- Department of Respiratory Disease and Critical Care Medicine, the Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China
| | - Y J Li
- Department of Respiratory Disease and Critical Care Medicine, the Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China
| | - F G Jin
- Department of Respiratory Disease and Critical Care Medicine, the Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China
| |
Collapse
|
190
|
Zhang L, Yang Y, Chen X, Li J, Pan J, He X, Lin L, Shi Y, Feng W, Xiong J, Yang K, Yu Q, Hu D, Sun Y, Zhang Q, Hu G, Li P, Shen L, Yang Q, Zhang B. 912MO A single-arm, open-label, multicenter phase II study of camrelizumab in patients with recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC) who had progressed on ≥2 lines of chemotherapy: CAPTAIN study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
191
|
Tan Q, Wang Y, Liu S, Luo R, Wang S, Liang T, Yang J, Xing P, Yao J, Wu D, Zhang Z, Dai J, Yu X, Han X, Shi Y. 1945P Distribution of anti-PD1/PDL1 autoantibodies in multiple cancer types and potential biomarker role for anti-PD1 therapy. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
192
|
Shi Y, Wang N, Zou QM. [Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)]. Zhonghua Yu Fang Yi Xue Za Zhi 2020; 54:614-619. [PMID: 32234130 DOI: 10.3760/cma.j.cn112150-20200317-00366] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The outbreak of 2019-novel coronavirus (2019-nCoV) infection poses a serious threat to global public health. Vaccination is an effective way to prevent the epidemic of the virus. 2019-nCoV along with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) belong to the same β-genus of coronavirus family. Basing on the previous experience and the technical platform of developing SARS-CoV and MERS-CoV vaccines, scientists from all over the world are working hard and quickly on the related fields. There are substantial progress in these fields including characterizing the 2019-nCoV virus, identification of candidate antigens and epitopes, establishment of animal models, characterizing the immune responses, and the design of vaccines. The development of 2019-nCoV vaccines covers all types: inactivated virus vaccine, recombinant protein vaccine, viral vector-based vaccine, mRNA vaccine, and DNA vaccine, et al. As of March 2020, two 2019-nCoV vaccines have entered phase I clinical trials. One is named as Ad5-nCoV developed by the Chinese Institute of Biotechnology of the Academy of Military Medical Sciences and Tianjin Cansino Biotechnology Inc. Ad5-nCoV is based on the replication-defective adenovirus type 5 as the vector to express 2019-nCoV spike protein. The another vaccine is mRNA-1273 developed by the National Institute of Allergy and Infectious Diseases and Moderna, Inc.. RNA-1273 is an mRNA vaccine expressing 2019-nCoV spike protein. Although the rapid development of 2019-nCoV vaccine, it still faces many unknown challenges, including the antigenic characteristics of the 2019-nCoV, the influence of antigenic variation, the protective immune response of host, the protection of the elderly population, and the downstream manufacturing process of the new vaccine. The safety and efficacy of vaccines are the first priority for vaccine development and should be carefully evaluated.
Collapse
Affiliation(s)
- Y Shi
- Institute of Biopharmaceutical Research, West China Hospital, Sichuan University, Chengdu 610041, China
| | - N Wang
- Institute of Biopharmaceutical Research, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Q M Zou
- National Engineering Research Center of Immunological Products, Army Medical University, Chongqing 400038, China
| |
Collapse
|
193
|
Li YY, Hu JJ, Cheng MN, Yang QP, Wu F, Fu C, Shi Y. [Relationship between both quality and duration of sleep and type 2 diabetes in middle-aged and elderly people in Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:1261-1265. [PMID: 32867433 DOI: 10.3760/cma.j.cn112338-20191230-00919] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the relationship between both quality and duration of sleep and type 2 diabetes in middle-aged and elderly people in Shanghai. Method: Baseline data was from the '2017 epidemiological survey in Shanghai community residents aged 35 and above on type 2 diabetes'. Restricted cubic splines were used to draw dose-response curves to show the relationship between PSQI score, sleep duration and type 2 diabetes. Logistic regression model was used to analyze the effects of quality and duration of sleep as well as the interaction, on type 2 diabetes. Results: Results showed that the average PSQI score was (4.09±0.10) points, the proportion of poor sleep quality was 12.55% (95%CI: 10.77-14.58) and the average sleep duration was (7.19±0.03) hours. The relationship between PSQI score and diabetes appeared linear, with the relationship between sleep duration and diabetes as U-shaped. After adjusting for confounders, both poor sleep quality (>7 for PSQI score) and short sleep duration (sleep duration <6 hours) significantly increased the risk of type 2 diabetes, with OR=1.17 (95%CI: 1.06-1.30) and 1.20 (95%CI: 1.01-1.41), respectively. From the interaction analysis, data showed that after adjusting for confounders, both sleep duration <6 hours (OR=1.30, 95%CI: 1.12-1.52) and ≥8 hours (OR=1.79, 95%CI: 1.04-3.07) with poor sleep quality would increase the risks on diabetes. Conclusion: Both poor sleep quality and short sleep duration were associated with the risk of diabetes, while long sleep duration was only associated with the risk of diabetes when accompanied by poor quality of sleep.
Collapse
Affiliation(s)
- Y Y Li
- Shanghai Municipal Center for Disease Control & Prevention, Shanghai 200336, China
| | - J J Hu
- Center for Disease Control and Prevention of Yangpu District, Shanghai 200090, China
| | - M N Cheng
- Shanghai Municipal Center for Disease Control & Prevention, Shanghai 200336, China
| | - Q P Yang
- Shanghai Municipal Center for Disease Control & Prevention, Shanghai 200336, China
| | - F Wu
- Shanghai Municipal Center for Disease Control & Prevention, Shanghai 200336, China
| | - C Fu
- Shanghai Municipal Center for Disease Control & Prevention, Shanghai 200336, China
| | - Y Shi
- Shanghai Municipal Center for Disease Control & Prevention, Shanghai 200336, China; National Clinical Research Center for Aging and Medicine, Shanghai 200040, China
| |
Collapse
|
194
|
Liu X, Chen M, Wang Y, Sun L, Zhang J, Shi Y, Wang J, Zhang H, Sun G, Baker PN, Luo X, Qi H. Prenatal anxiety and obstetric decisions among pregnant women in Wuhan and Chongqing during the COVID-19 outbreak: a cross-sectional study. BJOG 2020; 127:1229-1240. [PMID: 32583536 PMCID: PMC7362035 DOI: 10.1111/1471-0528.16381] [Citation(s) in RCA: 96] [Impact Index Per Article: 24.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/05/2020] [Indexed: 11/29/2022]
Abstract
OBJECTIVES To investigate the mental status of pregnant women and to determine their obstetric decisions during the COVID-19 outbreak. DESIGN Cross-sectional study. SETTING Two cities in China--Wuhan (epicentre) and Chongqing (a less affected city). POPULATION A total of 1947 pregnant women. METHODS We collected demographic, pregnancy and epidemic information from our pregnant subjects, along with their attitudes towards COVID-19 (using a self-constructed five-point scale). The Self-Rating Anxiety Scale (SAS) was used to assess anxiety status. Obstetric decision-making was also evaluated. The differences between cities in all of the above factors were compared and the factors that influenced anxiety levels were identified by multivariable analysis. MAIN OUTCOME MEASURES Anxiety status and its influencing factors. Obstetric decision-making. RESULTS Differences were observed between cities in some background characteristics and women's attitudes towards COVID-19 in Wuhan were more extreme. More women in Wuhan felt anxious (24.5 versus 10.4%). Factors that influenced anxiety also included household income, subjective symptom and attitudes. Overall, obstetric decisions also revealed city-based differences; these decisions mainly concerned hospital preference, time of prenatal care or delivery, mode of delivery and infant feeding. CONCLUSIONS The outbreak aggravated prenatal anxiety and the associated factors could be targets for psychological care. In parallel, key obstetric decision-making changed, emphasising the need for pertinent professional advice. Special support is essential for pregnant mothers during epidemics. TWEETABLE ABSTRACT The COVID-19 outbreak increased pregnant women's anxiety and affected their decision-making.
Collapse
Affiliation(s)
- X Liu
- Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.,China-Canada-New Zealand Joint Laboratory of Maternal and Fetal Medicine, Chongqing Medical University, Chongqing, China
| | - M Chen
- Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.,China-Canada-New Zealand Joint Laboratory of Maternal and Fetal Medicine, Chongqing Medical University, Chongqing, China.,Maternal and Child Health Hospital of Hubei Province, Wuhan, China
| | - Y Wang
- First Clinical Institute, Chongqing Medical University, Chongqing, China
| | - L Sun
- School of Public Health and Management, Chongqing Medical University, Chongqing, China
| | - J Zhang
- MOE-Shanghai Key Laboratory of Children's Environmental Health, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Y Shi
- Department of Neonatology, Children's Hospital of Chongqing Medical University, Chongqing, China
| | - J Wang
- Department of Neonatology, Children's Hospital of Chongqing Medical University, Chongqing, China
| | - H Zhang
- Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.,China-Canada-New Zealand Joint Laboratory of Maternal and Fetal Medicine, Chongqing Medical University, Chongqing, China
| | - G Sun
- Maternal and Child Health Hospital of Hubei Province, Wuhan, China
| | - P N Baker
- China-Canada-New Zealand Joint Laboratory of Maternal and Fetal Medicine, Chongqing Medical University, Chongqing, China.,College of Life Sciences, University of Leicester, Leicester, UK
| | - X Luo
- Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.,China-Canada-New Zealand Joint Laboratory of Maternal and Fetal Medicine, Chongqing Medical University, Chongqing, China
| | - H Qi
- Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.,China-Canada-New Zealand Joint Laboratory of Maternal and Fetal Medicine, Chongqing Medical University, Chongqing, China
| |
Collapse
|
195
|
Amill‐Rosario A, Segel J, Shi Y, Leslie D, Hillemeier M, Scanlon D. Private Payer Reimbursement Policy and Live‐Video Utilization for Outpatient Mental Health Care Among the Privately Insured. Health Serv Res 2020. [DOI: 10.1111/1475-6773.13391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Affiliation(s)
- A. Amill‐Rosario
- The Pennsylvania State University University Park PA United States
| | - J. Segel
- The Pennsylvania State University University Park PA United States
| | - Y. Shi
- The Pennsylvania State University University Park PA United States
| | - D. Leslie
- Penn State College of Medicine Hershey PA United States
| | - M. Hillemeier
- The Pennsylvania State University University Park PA United States
| | - D. Scanlon
- The Pennsylvania State University University Park PA United States
| |
Collapse
|
196
|
Shi Y, Li YY, Liu Y, Zheng B, Shang L, Li QH, Jia YJ, Sun WC, Duan ZC, He DS, Guo GQ, Ru K, Wang JX, Xiao ZJ, Wang HJ. [Clinical and laboratory characteristics in patients with myeloid neoplasms complicated with clonal T large granular lymphocyte proliferation]. Zhonghua Xue Ye Xue Za Zhi 2020; 41:276-281. [PMID: 32447929 PMCID: PMC7364924 DOI: 10.3760/cma.j.issn.0253-2727.2020.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the clinical manifestations and laboratory features in patients with myeloid neoplasms complicated with clonal T large granular lymphocyte (T-LGL) proliferation. Methods: The clinical data of 5 patients with myeloid neoplasms complicated with clonal T-LGL proliferation from November 2017 to November 2018 in Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College were analyzed retrospectively. Results: The median age was 60 years old. All patients had a history of abnormal peripheral blood cell counts for over 6 months. The absolute lymphocyte count in peripheral blood was less than 1.0×10(9)/L. In addition to the typical T-LGL phenotype, the immunophenotype was heterogenous including CD4(+)CD8(-) in 2 patients, the other 3 CD4(-)CD8(+). Four patients were αβ type T cells, the other one was γδ type. STAT3 mutation was detected in 1 patient by next-generation sequencing, the other 4 cases were negative. Conclusions: Clonal T-LGL proliferation with myeloid neoplasm develops in an indolent manner, mainly in elderly patients. Hemocytopenia is the most common manifestation. The diagnosis of T-LGL proliferation does not have specific criteria, that it should be differentiated from other T cell proliferative disorders, such as T-cell clones of undetermined significance. STAT3 or STAT5b mutation may help distinguish.
Collapse
Affiliation(s)
- Y Shi
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Y Y Li
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Y Liu
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - B Zheng
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - L Shang
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Q H Li
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Y J Jia
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - W C Sun
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Z C Duan
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - D S He
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - G Q Guo
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - K Ru
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - J X Wang
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - Z J Xiao
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| | - H J Wang
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Instituteof Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
| |
Collapse
|
197
|
Yu PF, Pang LL, Mao QS, Zou SC, Shi Y, Lin DJ. Dose dependency PM2.5 aggravated airway inflammation in asthmatic mice via down-regulating expression of ITGB4. Eur Rev Med Pharmacol Sci 2020; 23:1688-1697. [PMID: 30840294 DOI: 10.26355/eurrev_201902_17131] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE We aimed to investigate whether PM2.5 has the potential to exacerbate neutrophil airway inflammation and to analyze the underlying mechanisms. MATERIALS AND METHODS The high-volume air sampler (Laoying 2033B, Qingdao, China) was used to collect PM2.5 from January 01, 2016 to December 21, 2016 in Yantai, Shandong Province, China. BALB/c mice were divided into the following four groups: control group, ovalbumin (OVA) group, low-dose PM2.5 group and high-dose PM2.5 group. Mice except for control group were sensitized and challenged by OVA, and those in low-dose PM2.5 group and high-dose PM2.5 group were intranasally administered by PM2.5 suspension. Airway responsiveness of mice was measured. Enzyme-linked immunosorbent assay (ELISA) kit was used to evaluate the expressions of interleukin 17 (IL-17) and tumor necrosis factor-α (TNF-α) in bronchoalveolar lavage fluid (BALF) and serum samples. Cell counting in BALF and histological examination were measured to explore PM2.5-induced airway inflammation. Protein expression of Integrin β4 (ITGB4) was assessed by Western blot. RESULTS Airway hyperresponsiveness (AHR) exacerbated in PM2.5 exposed asthmatic mice in progressively increased doses of acetylcholine chloride (ACH). Levels of IL-17 and TNF-αin BALF and serum increased significantly in PM2.5 groups compared with other groups with significant differences between two PM2.5 groups. PM2.5 exposure exacerbated inflammatory cell infiltration and mucus secretion in airways of asthmatic mice. Percentage of neutrophils in PM2.5 groups was significantly higher in dose-dependent manner. OVA and PM2.5 co-exposure inhibited the expression of ITGB4. In particular, ITGB4 expression in mice of high-dose PM2.5 group was significantly lowered than the low-dose PM2.5 group. CONCLUSIONS We showed that PM2.5 exposure exacerbates neutrophil airway inflammation in asthmatic mice though up-regulating expressions of IL-17 and TNF-α but down-regulating the expression of ITGB4.
Collapse
Affiliation(s)
- P-F Yu
- Shandong University, Jinan, China.
| | | | | | | | | | | |
Collapse
|
198
|
Li C, Xin H, Shi Y, Mu J. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling. Hum Exp Toxicol 2020; 39:1725-1736. [PMID: 32672070 DOI: 10.1177/0960327120938845] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Tripartite motif-containing protein 24 (TRIM24) has currently emerged as a crucial cancer-related gene present in a wide range of human cancer types. However, the involvement of TRIM24 in acute myeloid leukemia (AML) has not been well investigated. The present study aims to investigate the significance, cellular function, and potential regulatory mechanism of TRIM24 in AML. We found that TRIM24 expression was significantly upregulated in AML compared with normal tissues. AML patients with low expression of TRIM24 had higher survival rates than those expressing TRIM24 at higher levels. High expression of TRIM24 was also detected in AML cells and its knockdown markedly restricted proliferation and promoted apoptosis in AML cells. Further investigation revealed that TRIM24 contributed to the regulation of Wnt/β-catenin signaling, which was associated with modulating the phosphorylation status of glycogen synthase kinase-3β (GSK-3β). Inactivation of GSK-3β partially reversed the TRIM24 knockdown-mediated antitumor effects observed in AML cells. Furthermore, knockdown of TRIM24 retarded the growth of AML-derived xenograft tumors in nude mice in vivo. Overall, these findings demonstrate that knockdown of TRIM24 impedes the AML tumor growth through the modulation of Wnt/GSK-3β/β-catenin signaling. These findings highlight the potential TRIM24 as an attractive anticancer target to treat AML.
Collapse
Affiliation(s)
- C Li
- Department of General Practice, 162798The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.,Department of Cardiology, 162798The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
| | - H Xin
- Department of Cardiology, 162798The First Affiliated Hospital of Xi'an Medical University, Xi'an, China
| | - Y Shi
- Department of General Practice, 162798The First Affiliated Hospital of Xi'an Medical University, Xi'an, China
| | - J Mu
- Department of Cardiology, 162798The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
| |
Collapse
|
199
|
Shi Y, Shi ZM. Dataset of wind blow sand erosion test on ultrasonic surface treated cementitious composites. Data Brief 2020; 31:105943. [PMID: 32671151 PMCID: PMC7347949 DOI: 10.1016/j.dib.2020.105943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2020] [Revised: 06/14/2020] [Accepted: 06/24/2020] [Indexed: 11/25/2022] Open
Abstract
In this paper, we take cement mortar and paste as specimens, a novelty method named ultrasonic surface treatment(UST) was employed to form a hardening surface layer on cementitious specimens to improve its wind-blown sand erosion resistance, surface hardness and apparent density. The specimens with curing ages of 1-day, 3-days, 7-days, and 28-days were adopted. The wind blown sand erosion test was carried out in a wind-blown sand erosion test system, which simulated a wind blown sand environment of a wind speed of 30 m/s and a sand feed rate of 30 g/min. The erosion angle of 30°, 60°, 90° were adopted. The mass loss in erosion process was measured, then the erosion resistance was calculated. The surface hardness was tested with a Vickers micro hardness tester. The apparent density of cement paste was measured with mass volume method. The data provided reveal the improvement on wind blown sand erosion resistance, surface hardnenss and apparent density of cementitious materials with ultrasonic surface treatment. That may be used in the investigation on improving the erosion resistance and to evaluate the effectiveness of the UST method on cementitious materials.
Collapse
Affiliation(s)
- Y Shi
- School of Materials Science and Engineering, Inner Mongolia University of Technology, Hohhot, Inner Mongolia, PR China.,Inner Mongolia Autonomous Region Engineering Research Center of Structure Inspection, Appraisal and Safety Assessment, Inner Mongolia University of Technology, Hohhot 010051, PR China
| | - Z M Shi
- School of Materials Science and Engineering, Inner Mongolia University of Technology, Hohhot, Inner Mongolia, PR China
| |
Collapse
|
200
|
Bao G, Lu H, Liang Y, Xu Z, Shi Y, Li J, Kong W, Liu J, Fang D, Gong Y, He S, He Q, Li X, Ci W, Zhou L. The copy number variation signatures in upper tract urothelial carcinoma define distinct subtypes with prognostic relevance. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34089-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|